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ABSTRACT
DENERVATION SUPERSENSITIVITY OF THE RAT VAS DEFERENS:
A ROLE FOR PROTEIN KINASE C
by
Sonny Thomas Abraham

A role for protein kinase C (PKC) in the denervation-induced supersensitivity
of the rat vas deferens was investigated. Chronict surgical denervation of the rat vas
deferens (up to 8 days) resulted in tissues that produced enhanced contractile responses
to norepinephrine (NE) in isolated organ baths. Single challenges of NE (10 pM)
produced 0.6 ±0.1 g of maximal tension in the control vas whereas in the paired,
denervated tissue 2.2 ± 0.3 g of tension was recorded (n-6). Cumulative
concentration-effect curves to NE produced in the denervated vas deferens were
shifted 18-fold to the left of the control response. Neurokinin A (NKA) responses
after denervation of the tissue were not significantly different from the control.
Denervation did not alter the contractile response to phorbol diacetate (PDA), a PKC
activator. Pretreatment of denervated and control vas deferens with 100 pM
nifedipine (a calcium channel blocker), significantly attenuated the contractile response
to NE. The responses in the control tissues were depressed by 88%, those in the
denervated vasa were only antagonized by 65% after nifedipine treatment.
Exposure of denervated and control vas deferens to 100 pM NE resulted in no
significant accumulation of diacylglycerol (DAG) from basal values. The molecular
species of DAG produced after receptor stimulation, in either tissue group, were not
different from those found in resting tissues. Denervation also had no effect on the
binding characteristics of membrane-associated PKC when assayed using the specific
ligand, pHJphorbol dibutyrate. Binding maxima of 4.8 ± 0.9 and 4.1 ± 0.4 pmol/mg
protein (n-4) were determined in the membrane fraction isolated from paired control
and denervated vas deferens, respectively. The dissociation constant for the ligand
was found to be 4.3 ± 0.6 and 3,5 ± 0.1 nM in the control and denervated groups,
respectively.
The PKC activity of resting vas deferens was not altered by chronic surgical
denervation, Denervated and control vas deferens that were stimulated with 100 pM
NE showed a time-dependent translocation of PKC from the cytosolic to the
membrane fraction of the tissue. In both tissue groups exposure to NE resulted in a 34 fold increase in the membrane-bound PKC activity, which remained elevated above
basal values for up to 20 mln. The rate of translocation of PKC was faster in
denervated vasa (maximal at 5 min after NE) when compared to the control (maximal
iii

at 20 min), but the maximal amount of the enzyme activated was the same for the two
tissue groups. The ability of NKA, 60 mM Kf-depoIarization and PDB (PKC
activator) to produce translocation of the PKC was not altered by denervation of the
vas deferens.
In conclusion, surgical denervation of the rat vas deferens produced tissues that
exhibited enhanced contractile activity when exposed to NE but not NKA. The
apparent resistance of the denervated tissue to calcium channel blockade (with
nifedipine) may indicate either an enhanced sensitivity of the contractile apparatus to
Ca2* or a decreased dependence of the tissue on extracellular CaIf after denervation.
The unaltered basal DAO or PKC levels after denervation would indicate that the
supersensitive response is not due to their elevation under resting conditions.
However, the increased rate of activation of PKC in denervated tissue, in response to
NE, is consistent with a positive role for the enzyme in the enhanced contractile
activity of the rat vas deferens.
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CHAPTER 1
Introduction

Survey of Supersensitivitv in Various Organs
The first report of denervation-induced supersensitivity appeared in 1855 when
Budge observed a greater pupillary dilation of irides after sectioning of the
postganglionic fibers from the superior cervical ganglia as compared with sectioning
the preganglionic fibers cited by (Fleming et al„ 1973). A mechanism for this
phenomenon was not described until about fifty years later when Langendorff
discovered that the "paradoxical" dilation of the denervated iris (postganglionic nerve
sectioned) versus the decentralized iris (preganglionic nerve sectioned) was due to
circulating substances from the adrenal glands. This phenomenon is now known to be
due to enhanced sensitivity of denervated irides to circulating catecholamines released
from the adrenal medulla (Fleming et al., 1973).
Thesleffe and others (Thesleffe, 1960) reported the development of
supersensitivity of skeletal muscle when denervation resulted in greatly enhanced
contractile response to acetylcholine (ACh). The area of the muscle sensitive to ACh,
which is normally confined to the motor end-plate, spread outward to cover the entire
surface of the muscle fiber. Electrophysiological and radiolabelled studies indicated a
spread in nicotinic receptors horn the end-plate region to cover the entire surface of
the muscle (Fleming et al., 1973; Askmark and Gillberg, 1987). The increase in the
number of nicotinic receptors, as determined by binding studies, after denervation

(Askmark and Gillberg, 1987) was corroborated by reports of increased mRNA for the
a-subunit of the receptor protein after denervation (Shieh et al.t 1987). These findings,
however, did not entirely explain the resulting contractile response of denervated
skeletal muscle to non-cholinergic agents (e.g. histamine, serotonin, bradykinin and
caffeine) which are not seen in normally innervated muscle.
Westfall and Fleming (1968a) showed that chronic catecholamine depletion of
adrenergic nerves by reserpine resulted in enhanced sensitivity of cardiac muscle to the
chronotropic effects of norepinephrine and calcium in the dog as well as the guinea
pig (Westfall and Fleming, 1968b). However, changes in the inotropic effect of
various agonists after reseTpine treatment was not consistently seen. Chronic reserpine
treatment of the rat has also been shown to produce enhanced chronotropic sensitivity
of spontaneously beating right atria to isoproterenol (Rice et al., 1987).
Denervation studies have also been conducted in a number of smooth muscle
organs from various species. Trendelenberg (1963) and Langer (1966) describe
extensive work done in producing sensitivity changes in the cat nictitating membrane
by reserpine treatment or sectioning of the preganglionic fibers innervating the organ.
Akhtar and Abdel-Latif (1986) were able to denervate the iris by surgically removing
the superior cervical ganglion in the rabbit. In isolated organ baths denervated irides
were 17-fold more sensitive to the contractile effect of NE as control tissues.
Chronic treatment of guinea pigs with the ganglionic blocking agent
chlorisondamine resulted in increased sensitivity of the isolated ileum to acetylcholine
(Fleming, 1968). The production of supersensitivity in vascular smooth muscle after
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adrenergic neurotransmitter depletion with reserpine has been observed less
consistently . This is probably due to the fact that changes in sensitivity were usually
measured in the intact animal where difficulty in delineating purely postjunctional
responses was encountered. Oranges in resting blood pressure, basal adrenergic tone,
and uptake and metabolism of pressor agents that often results from reserpine
treatment may account for much of the inconsistency (Fleming et al., 1973).

Supersensitivitv of the Rat Vas Deferens.
Birmingham (1968) showed that stripping the serous coat around the vas
deferens caused a loss of NE content as well as catecholamine fluorescence in the
tissue eight days after the procedure. Vas deferens denervated in this manner
exhibited about a 20-fold increase in sensitivity to the contractile stimulus of NE in
vitro,
Kasuya et al. (1969) were able to produce supersensitivity in the rat vas
deferens by destroying the hypogastric plexus from which short postganglionic fibers
innervate the vas deferens (Sjostrand, 1965), This was achieved by crashing the
hypogastric nerve plexus and stripping the serous coat from the most prostatic end of
the vas (before the deferential artery meets the body of the vas deferens). This
method had the advantage of causing less bleeding of the tissue when compared to the
method of Birmingham (1968). Vasa denervated in this manner also showed marked
loss in NE content and catecholamine fluorescence four days after the procedure,
implying a nearly complete destruction of adrenergic nerves in the tissue. In vitro,

these tissues showed a greatly enhanced contractile response to NE that was
characterized by significant leftward shifts in the concentration-effect (C-E) curve and
increases in the maximal contractile force generated by the tissue. This denervationinduced supersensitivity was also exhibited by acetylcholine, angiotensin II, high
potassium and barium. The authors concluded that surgical denervation produced a
nonspecific supersensitivity of the vas deferens since a number of dissimilar agents
revealed the enhanced sensitivity of the tissue.
Pharmacological destruction of adrenergic nerves with 6-hydroxydopamine was
also shown to produce equivalent supersensitivity in the rat vas deferens as the
surgical procedure (Westfall, 1977). In the same study chronic reserpine treatment
produced more modest changes in sensitivity with smaller shifts in the NE
concentration-effect curves without a change in the maximal force produced by the
tissue.

Mechanisms of Sunersensitivitv in the Rat Vas Deferens
Westfall et al. (1977) made the initial observation of about 100% increase in
nexal contacts between smooth muscle cells from denervated vas deferens but not
reserpine-treated tissues, as compared to control vasa. The authors postulated
increased intercellular coupling, via nexal contacts, would mediate the increased
maximal contractile force in response to various agents. However such nexal contacts
may be largely artifactual due to the preparative procedure used (permanganateflxation) since Paton et al. (1976) did not observe any nexal junctions between cells

when the normal vas deferens was fixed with glutaraldehyde prior to electron
microscopy.
The electrophysiological characteristics of the smooth muscle cells after
denervation of the vas deferens were studied by Goto et at. (1978). This group
reported no change in the resting membrane potential after denervation, however, a 6.5
mV reduction in the threshold potential to depolarization (by an external electrode)
was observed. Hie authors also measured the propagation of electrotonic potential
through the tissue and found that the spread of excitation through denervated vasa was
markedly improved when compared to control tissues. It was concluded that the
denervation-induced change in threshold potential and electrical propagation would
result in increased sensitivity of the tissue to agents that depolarize the cell membrane.
The change in the electrical conduction of denervated tissues was also consistent with
the authors* earlier observation of increased nexal contacts between cells in denervated
vasa,
Since catecholamines initiate contractile response of the vas deferens by
activating the a,-adrenoceptor, changes in receptor characteristics after chronic
denervation were studied by Hata et al. (1981). Using [JH]WB4101 as a specific
ligand for Or adrenoceptors these authors described a significant decrease in receptor
number without a change in the affinity of the receptor, after chronic denervation of
the vas deferens. However, the ability of epinephrine and phenylephrine to displace
[3H]WB4101 binding was significantly enhanced in denervated vasa whereas that of
phentolamine and ergotamine did not change, The authors concluded that an increased

affinity of a ,-adrenoceptors for agonists (epinephrine, phenylephrine) but not
antagonists (WB4101, phentolanune) resulted after denervation of the vas. Such an
increase in agonist affinity for the receptor was proposed to mediate the observed
supersensitivity.
Rice (1983) found no change in the a,-adrenoceptor population of rat vas
deferens after denervation when assayed using [3H]WB4101 as the ligand. Further, the
ability of Epi to displace bound [3H]WB4101 in denervated or control vasa was not
found to be different. The reason for the discrepancy between these two studies is
not readily apparent.
More evidence for a lack of denervation-induced change in receptor
characteristics was presented by Abel et al. (1985) who found no difference in the a,adrenoceptors from denervated and control tissues, This group used [,15I]BE2254 as a
specific ligand for the receptor binding assay. The ability of NE to displace this
ligand from its binding site was not different in the two tissue groups either.
Additionally, these authors reported that neither the Kd of NE nor the number of
receptors was altered by denervation when determined in intact vasa by the receptorinactivation method of Furchgott (1966),
Evidence for post-receptor events mediating enhanced sensitivity after
denervation was reported by Takenawa et al. (1983) who showed an increased
accumulation of phosphatidic acid (PA) after NE stimulation in these tissues.
However, NE-lnduced hydrolysis of phosphatidylinositol-4,5-blsphosphate (PIP3) in
denervated tissues was not significantly different from that in control vas. The authors

thought their results were consistent with a rote for phosphatidic acid in increasing
calcium-influx into supersensitive cells thereby mediating enhanced contractile
response to agonists. A role for PA in mediating influx of cations has been proposed
by various groups in the past (Putney et al, 1980; Salmon and Honeyman, 1980), but
is not well accepted currently. Thus the significance of increased accumulation of PA
in denervated tissues after receptor stimulation remains to be determined.
A passible link between enhanced contractile response and increased calcium
mobilization in denervated rat vas deferens was investigated by Minneman et al.
(1988). In 18-day denervated vasa, NE was found to be 10-fold more potent in
causing total pH] inositol phosphate accumulation when compared to control tissues.
No difference in the maximal amounts of pH] IPs formed was noted between the two
tissues, In the presence of uptake and metabolism inhibitors, control tissues showed
an equivalent increase in potency to NE-induced production of [}H]IPs as in the
denervated group. The authors reasoned that the increased potency of NE in causing
IP formation after denervation was due to loss of uptake and metabolism of
exogenously applied NE (prejunctional phenomenon). This was supported by findings
that the potency of phenylephrine and carbachol (not subject to uptake and
metabolism as NE) in elevating IP levels was unchanged after denervation. The
conclusion was reached that chronic denervation of the rat vas deferens does not result
in an enhanced coupling of a ,-adrenoceptors to PIP2 hydrolysis.

s
General Considerations in the Production of Supersensitivilv

Slow Time-course of Development.
Structures that are denervated or depleted of neurotransmitter take a number of
days before maximal supersensitivity results. Daily administration of reserpine for 714 days was required to see optimal sensitivity development in the cat nictitating
membrane (Fleming and Trendelenburg, 1961). Supersensitivity was maximally
expressed about 4 days after surgical denervation of the rat vas deferens (Kasuya et
al., 1969).

NonspecificJjatute_oLthe_Enhanced Sensitivity.
Chronic reserpine treatment resulted in increased sensitivity of rabbit aortic
strips to NE, acetylcholine and potassium (Hudgins and Fleming, 1966). Kasuya et al.
(1969) reported that denervation of the rat vas deferens resulted in supersensitivity of
the organ to various dissimilar contractile agents as well. This nonspecific nature of
the change in sensitivity is good evidence for some common post-receptor alteration in
the cells which results in enhanced sensitivity to a number of different contractile
agents.

Preiunctional and.Eost junctional Suoersensitivitv.
Tissues which receive predominantly adrenergic innervation appear to produce
different types of supersensitivity when denervated or depleted of transmitter with
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reserpine. Prejunctional supersensitivity is seen with catecholamines which are subject
to neuronal uptake (Trendelenburg, 1966). Thus tissues lacking adrenergic nerve
endings (denervated) or with impaired uptake into the nerve terminal (cocaine treated)
would exhibit a decreased threshold for activation by NG simply due to increased
concentration of agonist at the receptor. This would result in a leftward shift in the
agonist concentration-effect curve. Postjunctional supersensitivity is independent of
neuronal uptake and would be exhibited by adrenergic as well as non-adrenergic
agents. The enhanced sensitivity to NE in the denervated vas deferens was observed
as an 18-fold shift in the agonist C-E relationship as well as an increase in the
maximal contractile response of the tissue (Abraham and Rice, 1992a). Using
inhibitors of neuronal and extra-neuronal NE uptake (cocaine, hydrocortisone) and
metabolism (U-0521) in normal tissue it was determined that prejunctional
supersensitivity probably accounted for about a six-fold leftward shift in the NE C-E
curve. The remaining three-fold shift in the NE C-E curve as well as the increase in
the maximal contractile response appear to be due to postjunctional alteration in tissue
sensitivity.

Excitation-Contraction Coupling in Smooth Muscle

The_Central_Role_Qf_Caicium
Early studies by Ringer (1883) showed the importance of calcium in muscle
contraction when the isolated frog heart ceased to beat and became insensitive to

stimulation in isotonic sodium chloride solution. Addition of calcium chloride to the
solution restored the spontaneous activity of the heart which was maintained for a
prolonged period. Production of contractile activity in skeletal muscle fibers by
intracellular application of calcium via micropipette was more direct evidence for a
role for calcium ions in muscle contraction (Ebashi, 1980). A central role for calcium
has also been shown in smooth muscle contraction (Bozler, 1969). Since then work
by numerous laboratories has shown that the elevation in intracellular ftee calcium is
the primary initiator of contractile activity in smooth muscle (Ramos et al., 1986).
As in skeletal muscle, smooth muscle has been shown to possess actin and
myosin filaments but in less than parallel orientation with the cell. Unlike in skeletal
muscle the Z-line which anchors actin and myosin filaments is missing and the fibers
appear to be attached to cytoskeletal elements via dense bodies (Somlyo et al., 1977).
The myosin isolated from various smooth muscle cells appears to be much like that in
skeletal muscle, having one pair of heavy polypeptide chains (200 kDa M.W.) and two
pairs of light chains (15-20 kDa).
Adelstein et al. (1977) described a cellular kinase which was able to
phosphoiylate the light chains of smooth muscle myosin in the presence of calcium.
They also showed that this light chain phosphorylation increased the ability of actin
to stimulate the ATPase activity of the myosin head. From these results they proposed
a model by which elevation in intracellular calcium above 0 . 1 - 1 pM would activate
myosin light chain kinase. This enzyme would in turn phosphoiylate the 20 kDa light
chains of myosin resulting in actin-mediated ATPase activity of the myosin head with
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subsequent actin-myosin crossbridge cycling and muscle contraction. With the
discovery of a calcium binding protein (calmodulin) which activates MLCK, the
cascade for production of contractile response can now be linked to elevations in
cytoplasmic calcium (Kamm and Stull, 1985),
Contractile force in smooth muscle is thought to develop when the myosin
head interacts with the actin filament and undergoes a conformational change at the
"hinge" region of the heavy chain. This causes the myosin head to pull on the actin
filament to produce a power stroke resulting in the myosin and actin filaments sliding
past each other (Murphy, 1976). The energy for this stroke is derived from bound
ATP which is hydrolyzed to ADP and P( by the slow ATPase activity of the myosin
head. During the power stroke the bound ADP and Pf are released and this exposes
the site for ATP binding which results in detachment of the myosin head from actin.
Subsequent ATP hydrolysis returns the myosin head to the "cocked" state in position
to interact with a new site on the actin filament further down its length and the cycle
is repeated. This results in the myosin head "walking" along the actin filament and
many such events in parallel eventually shorten the cell.

Coupling of Receptors to Calcium Mobilization
It is quite clear that intracellular Ca3* is the fundamental second messenger for
the production of muscle contraction and it appears that receptor activation results in
its mobilization (Michell, 1975). What remains to be determined is how cell-surface
receptor stimulation results in this event. Since early observations of hormone-induced
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phosphotnositide metabolism (Hokin and Holdn, 1953} it has become increasingly
accepted that CaJ* mobilization by hormones is linked to this early membrane event.
These receptors appear to be linked via guanine nucleotide binding proteins (G
proteins) to a plasma-membrane bound phospholipase C which is able to hydrolyze
membrane phospholipids, primarily phosphatidylinositol-4,5-bisphosphate (PIP2), to
produce inositol-1,4,5-trisphosphate (IP3) and 1,2-diacylglycerol (DAG) (Berridge,
1984).
Evidence for a link between IP3 and Caa*-mobilization arose from work in
permeabilized hepatic and pancreatic cells where IP3 was able to release cellular stores
of Ca1* in a low calcium environment (Streb et al., 1983). This release of intracellular
Ca1* was shown to be from non-mitochondrial, non-secretory granule microsomal
fraction of cells and quite specific for IP3 since inositol-1,4-bisphosphate, inositol-1phosphate or inositol-1,2-cyclic phosphate were not able to elicit this action.
Photolysis of caged IP3 by laser pulse has also been shown to produce contractile
activity in smooth muscle (Walker et at., 1987). A role for other inositol
polyphosphates (IP4, IPj, etc.) in CaJ>-mobilization from extracellular sources has also
been proposed but remains without firm supportive evidence.
In the rat vas deferens, Fox et al. (1985) showed that concentration-dependent
activation of a (-adrenoceptors by NE resulted in significant inositol phosphate
accumulation. It was also reported that partial agonists which were only able to
produce 60% or less of the contractile response of NE were able to elicit 70-98% of
the NE-induced IP accumulation. The same group (Han et al., 1987) also published a
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report showing that incubation of the vas with a,-adrenoceptor antagonists WB4101
and benoxathian prior to NG exposure inhibited the contractile activity of the vas to a
greater extent than it did the elevation in IPs.
This dissociation of inositol phosphate accumulation from contractile response
revealed by partial agonists and antagonists was used by the authors to postulate two
distinct subtypes of a,-adrenoceptor, one which appears to mediate contractile
response ( a lb-type) and the other coupled to PIP2 hydrolysis (a,,-type). Additionally
the same paper showed that the normal vas deferens was very dependent on
extracellular Ca2* for the production of contractile force in response to NE. These
results taken together make the physiological role of IP3 in mediating contractile
response in the vas deferens rather ambiguous. To explain such discrepancies Putney
(1986) and Irvine and Moore (1986) have proposed models in which release of
intracellular Ca3f promotes influx of Ca3* to maintain high enough cytosolic Ca2* to
mediate cellular response as well as to refill depleted intracellular stores.

The Role of Protein Kinase C
A role for 1,2-diacylglycerol (DAG), produced as a result of PIP2 hydrolysis
(Fig. 1), was first proposed by Nishizuka's group who showed that protein kinase C
(PKQ was dependent on unsaturated diacylglycerol for activation (Takai et al., 1979).
They were able to show that PKC was activated during thrombin stimulation of
platelets resulting in phosphorylation of specific intracellular proteins (Kawahara et al.,
1980). Since then PKC has been identified in almost all cell types and found to

perform multiple functions (Nishizuka, 1988), The protein is found mostly in the
cytosol in soluble form with smaller amounts associated with the plasma membrane,
nuclear membrane and cytoskeletal filaments. This 82kDa protein possesses a
regulatory domain which binds Ca1*, phosphatidylserine (PS) and DAG or phorbol
esters as well as a catalytic domain which binds ATP.
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Figure 1 Scheme for CaJ*-mobilization and contractile activity in smooth muscle.
Gp, G-protein; PLC, phospholipase C; PIP2, phosphatidylinositol-4,5-bisphospliale;
IP3, inositol-1,4,5-trisphosphate; DAG, 1,2-diacylglycerol; PKC, protein kinase C;
MLCK, myosin light chain kinase; MLC, myosin light chain.
The enzyme functions optimally in the presence of DAG, PS and Ca1* which

results in the exposure of the catalytic domain to serine and threonine phosphorylation
sites on substrate proteins (Bell and Bums, 1991). Phorbol esters (PDB, PMA etc.)
appear to bind to the same site on PKC as DAG and thus are able to activate the
enzyme in a manner similar to the endogenous activator (Konig et al.t 1985). During
physiological stimulation cytosolic PKC is thought to become associated with the
plasma membrane, where it is in proximity with PS and DAG in the presence of Ca2*
(Huang; 1989). The primary stimulus for this translocation of PKC appears to be the
rise in intracellular free Ca1* (Ho et al., 1988), however, others maintain that sustained
elevation in membrane DAG may be responsible for PKC translocation (Rasmussen et
al., 1987).
Molecular cloning techniques have identified several isozymes of PKC, most
notably a, pi, pil, Y. 6* e, ft q and L, of which a - y ate dependent on Ca1* for
activity while 6 - L appear to be Ca1*-independent (Bell and Bums, 1991). Smooth
muscle cells contain the Ca2*-dependent a , p and y subtypes (Singer et al., 1992) as
well as the Ca3*-independent e and ( isoforms (Khalil et al., 1992). The role of the
various subtypes of PKC in smooth muscle is largely unknown although there does
appear to be some differential activation of the different isoforms during receptor
stimulation (Singer et al., 1992; Khalil et al., 1992).
Protein kinase C has been proposed to maintain sustained contraction of
smooth muscle since: (i) PKC-mediated contractile response by phorbol esters (PDB)
takes over an hour to develop maximally (Merkel et al., 1991); (ii) PKC-mediated
phosphorylation of cellular proteins desmln, synemin and caldesmon appear after about
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phosphorylation of cellular proteins desmin, synemin and caldesmon appear after about
1 hour of agonist stimulation. The role of PKC in smooth muscle has been proposed
to be to phosphorylate these cellular proteins which may then play a role in
modulating sustained muscle contraction (Rasmussen et al., 1987). However, a role
for PKC in initiating and maintaining smooth muscle contraction has been presented in
non-vascular smooth muscle (Menkes et al., 1986; Abraham and Rice, 1992b).
In intact iris smooth muscle Howe and Abdel-Latif (1988) have shown that
PKC activation is able to phosphorylate myosin light chain (MLC) at a site distinct
from that of myosin light chain kinase, The relevance of this action on muscle
contraction is unknown but the phosphorylation of MLC preceded the production of
contractile response in the tissue by phorbol dibutyrate (PDB). Lacerada et al. (1988)
as well as Souhrada and Souhrada (1989) have shown that PKC activation can enhance
Caa*-influx into muscle cells and have offered this as the mechanism by which PKC
mediated contractile response occurs.

Statement of the Problem
The work of numerous groups has shown that supersensitivity in smooth
muscle results from the withdrawal of the endogenous neurotransmitter from the nerve
endings in the tissue (Fleming et al., 1973). In the rat vas deferens the resulting
supersensitivity is thought to be due to postjunctional alteration in the smooth muscle
cells (Kasuya et al., 1969). However, work by various investigators has failed to
provide clear evidence of cellular changes which would explain the nonspecific
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supersensitivity to dissimilar contractile agents.
The increase in nexal contacts between smooth muscle cells after denervation
of the vas deferens has been proposed to increase electromechanical coupling between
cells and result in enhanced contractile response to depolarizing agents. However, it is
not clear whether the nexal contacts reported to exist in control vasa alone, as reported
by Westfall et al. (1977), are an artifact since one other group has reported no nexal
connections in the normal rat vas deferens (Paton et al., 1976) while a second group
(Daniel et al., 1976) has shown that the technique used by Westfall's group may
actually contribute to increased nexal structures.
The elevation in threshold potential after denervation of the vas deferens has
also been proposed to result in enhanced response to depolarizing agents (Goto et al.,
1978). This change would result in increased ease by which agents could depolarize
the muscle cell membrane and thus conceivably decrease the threshold concentration
of agonists in initiating contractile activity (resultant leftward shift in the C-E curve).
However, apart from a decrease in the threshold concentration and lowered ECM, a
significant elevation in the maximal contractile force results after denervation. This
phenomenon cannot be explained by the alteration in the threshold potential of the cell
membrane.
Takenawa et al., (1983) noted an enhanced accumulation of phosphatidic acid
in response to NE in denervated vasa as compared to control responses. The PA was
thought to increase Ca1* mobilization and thus promote the enhanced contractile
response to various agonists. Such a role for PA is not borne out by current
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investigations and in any case, would not explain the increased sensitivity to high K*
and Ba3* which presumably do not occur by elevation in cellular second messengers.
A role for altered a (-adrenoceptors in mediating the supersensitivity
phenomenon was ruled out when no change in the number or binding affinities of the
receptor were observed after denervation (Rice, 1983; Abel et al., 1985). Coupling of
a ,-adrenoceptors to PIP2 hydrolysis was not found to be significantly changed after
surgical denervation of the vas deferens (Takenawa et al., 1983; Minneman et al.,
1988) and so increased inositol phosphate production could not explain the
supersensitivity response.
Increased sensitivity to agonists in other smooth muscle systems have
implicated changes in protein kinase C activity as a causative factor. Unilateral
superior cervical gangllonectomy in rabbits has produced supersensitivity to NG in
isolated iris muscle (Akhtar and Abdel-Latif, 1986). The authors reported an increase
of 30% in cytosolic PKC activity of denervated hides when compared to control
tissues,
The caudal artery (Aqel et al., 1987) and thoracic aorta (Lograno et al., 1989)
from spontaneously hypertensive rats (SHRs) has been shown to exhibit enhanced
contractile response to NE and elevated K* relative to the response of tissues from
Wistar-Kyoto (WKY) rats. Phorbol esters (PMA) as well as non-phorbol activators of
PKC (mezerein) have been shown to produce greater contractile response in the
mesenteric arteries of stroke-prone SHRs when compared with WKY vessels CRiria
and Webb, 1987). An increase in PKC activity was proposed to mediate the enhanced
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contractile response of aortic muscle strips from SHRs since the NG response in these
tissues was more susceptible to antagonism by H-7 (PKC inhibitor) when compared to
WKY tissues (Shibata et al., 1990). Renal arteries from SHRs showed increases in
cytosolic PKC activity relative to WKY controls, but such differences were not seen in
the aortas of the same animals (Silver et al., 1992). Bazan et al. (1992) also reported
no difference in PKC activities from aortas of SHRs and WKY rats, although the
ability of phorbol esters to activate PKC (translocation from cytosolic to membrane
compartment) was greater in the SHR tissue.
There is significant evidence that various pathological and adaptive conditions
involve increased receptor or tissue sensitivity. Altered responsiveness of blood
vessels from hypertensive animals to contractile agents has been outlined above.
Rebound hypertension after rapid withdrawal of clonidine during antihypertensive
therapy may be due to increased NE released from sympathetic nerves as well as
increased receptor sensitivity of the heart and vascular muscle to circulating
catecholamines (Hansson et a)., 1973). Normal subjects receiving guanethidine (which
interferes with sympathetic neurotransmission) for 3 days developed supersensitivity to
the arrhythmic effects of administered catecholamines (Fleming et al., 1973).
Supersensitivity of cardiac muscle to circulating catecholamines has been proposed to
maintain myocardial function of the transplanted heart in the absence of sympathetic
innervation (Donald, 1973).
The rat vas deferens affords a smooth muscle system whereby sensitivity
changes may be consistently induced and then studied, Application of this knowledge
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may further a better understanding of such pathophysiological alterations and
eventually lead to better therapeutic regimes for their management.
At a more fundamental levelt such investigations would lead to a better
understanding of smooth muscle function and plasticity. Although the primary
initiation of contractile activity in smooth muscle appears to be via myosin light chain
phosphorylation by a specific kinase (MLCK), many other cellular proteins (PKC,
Caldesmon, desmin, etc.) may play a role in regulating this activity (Rasmussen et a l,
1987). What is unclear is the extent to which these various cellular proteins may
function in smooth muscle response. The present work attempts to define the
contribution of PKC in mediating contractile function in the vas deferens.
Additionally, if alterations in cellular proteins are found with chronic denervation, a
mechanism by which smooth muscle cells may enhance cell surface signaling would
be implicated.

Aim? pf the Study
The present study was designed to evaluate the role of protein kinase C in the
tissue supersensitivity that results from chronic denervation of the rat vas deferens.
Experiments were done to determine a number of parameters which would be
indicative of altered PKC function in denervated tissues when compared to the control
vas deferens. The experimental goals of the study are as follows:
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1. to determine the functional relevance of PKC in the contractile response of the vas
deferens by use of PKC activators as well as inhibitors. These experiments would
provide information as to the extent to which PKC mediates normal contractile
function in response to receptor and non-receptor agents.

2. to compare the ability of the phorbol PKC activators to produce contractile
responses in the denervated and control vas. If enhanced response after
denervation is due to nonspecific increases in PKC activation, these experiments
could provide evidence for such alterations.

3. to determine the amounts of 1,2-diacyl glycerol produced in denervated and control
vasa in response to receptor stimulation as well as to analyze the various molecular
species of DAG produced. These experiments would indicate an increased
activation of PKC in denervated tissues due to enhanced levels of the endogenous
activator (DAG) formed subsequent to receptor stimulation. Changes in the
molecular species of DAGs produced could indicate changes in a,-adrenoceptor
coupling to different membrane phospholipases (PLC, PLD, etc.),
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4. to evaluate the binding characteristics of membrane-bound PKC from denervated
and control vasa using the ligand [1H]phorboM2,13-dibutyrate. An increase in
basal PKC in the membranes or enhanced affinity of the protein for activators
following denervation would provide a mechanism by which PKC activation may
be altered.

5. to determine the activation of PKC in denervated and control vas deferens as
indicated by translocation of PKC from the cytosolic to the membrane fraction of
the cell. These experiments would reveal differences in the ability of receptor
stimulation to activate PKC in the two tissue groups. Non-receptor-mediated (K*
and phorbol esters) translocation of PKC in the two groups would also be studied.

CHAPTER 2
Materials and Methods

Animals and Tissues
Male CD rats (VAF) bred from Charles River CD rats in the Division of
Laboratory Animal Resources were used in the study. On occasion additional male
CD (VAF) rats were purchased from Charles River Labs (Wilmington, Ma.). Animals
were housed and cared for in the animal care facility according to the guidelines of the
American Association for Accreditation of Laboratory Animal Care. They had free
access to food and water and were maintained on a 12 hour light/dark cycle. Rats
weighing 300-600 g were used to obtain tissue for the experiments herein. The
animals were euthanized by exposure to carbon dioxide gas until loss of
consciousness, followed by cervical dislocation.
Whole vas deferens from the base of the bladder to the epididymis were
dissected and placed in ice-cold, oxygenated, physiological salt solution (PSS). Vasa
were carefully cleaned of the connective tissue sheath, adherent blood vessels and fat,
while under ice-cold PSS, using fine forceps. When appropriate, tissue wet weights
were obtained soon after tissues were cleaned and while still cold,
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Surgical Denervation Procedure
The denervation procedure was performed essentially according to the method
introduced by Kasuya et al. (1969). Rats were anesthetized with 60 mg/kg
pentobarbital sodium, administered via intraperitoneal (i.p.) injection. Later the
anesthetic was changed to a combination of ketamine (60 mg/kg) and xylazine (12
mg/kg) also administered by the i.p. route. The ketamine/xylazine combination was
found to produce better surgical analgesia and anesthesia as evidenced by decreased
incision and pedal reflex. The dose of pentobarbital used was also less consistent in
inducing rapid anesthesia or recovery of the animal after surgery. Butorphanol (2
mg/kg, subcutaneous injection) was also given to the animals prior to surgical incision.
This long-acting analgesic helped to speed the recovery of the animal after surgery.
Hie surgical procedure was carried out according to aseptic guidelines using
sterile instruments and materials (Cunliffe-Beamer, 1993). The abdomen was shaved
using animal clippers and the area cleaned with 95% ethanol followed by povidoneiodine solution. A 3-4 cm long, 1 cm ofF-midline, incision was made in the skin and
abdominal muscle layer of the rat using a scalpel. The bladder as well as the seminal
vesicle and prostate on the surgical side were exposed and immobilized with
hemostats. The testicle on the surgical side was pulled out of the scrotal sack until the
area where the vas deferens meets the base of the bladder was exposed (Fig. 2).

The

adherent fat in the area was removed with forceps and the vas deferens was freed from
its mesenteric attachments.

Figure 2. View of visceral organs during denervation surgery. Dashed lines indicate
nerves entering the vas deferens and the arrow points to the area of phenol application.
Under a magnifying lens up to 3 individual nerve fibers could be seen entering the vas
deferens via the connective tissue sheath, while, a fourth usually entered along with
the deferential artery. Using fine forceps the connective tissue sheath around the
tissue, from the base of the bladder to the junction of the deferential artery and vas
deferens was carefully removed with minimal bleeding.
To destroy the nerves which entered with the artery, as well any that had been
missed with the forceps, 3 to 4 drops of 5% phenol (wt./vol in water) were applied to
the area. Subsequently, the abdominal musculature was closed using silk surgical
suture and the skin incision was secured with metal wound clips. The animal was
then wrapped in paper and placed in the cage for recovery. The right or left vas
deferens was randomly denervated in each animal and the contralateral tissue was left
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intact as the control. The rats were allowed to recover usually for 6 to 8 days before
the denervated and control tissues were dissected out.

Contractile Studies of the Vas deferens

Tissue Preparation and Equilibration
Adult, male CD rats (300-600 g) were used as the source of fresh vas deferens
in these studies.

The animals were anesthetized with carbon dioxide and killed by

cervical dislocation.

Both vasa deferentia were rapidly removed and placed in ice-

cold, oxygenated, physiological salt solution (PSS).

The tissues were cleaned of

blood vessels and adhering connective tissue (under cold buffer) using fine forceps.
The vasa were then placed in individual jacketed organ baths containing PSS (see
Appendix A for preparation scheme) of the following composition (mM); NaCl (113);
KC1 (4.7); CaCIj (2.5); MgS04 (0.57); NaHCO, (25); NaHP04 (1.01) and dextrose
(5.55).

The buffer was continuously aerated with a mixture of 95% 0 2 and 5% C 0 2

and maintained at 37°C throughout the experiment.

Measurement of Contractile Response
Vasa deferentia were suspended vertically in 25 ml organ baths with one end
attached to Grass force-displacement transducers (FT03C) and the other end to the
bottom of the organ bath via cotton thread. The tissues were maintained at 250-300
mg resting tension, and isometric contractile responses were recorded by a Grass
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Model 7D polygraph (Quincy, MA.).

Following a 60-90 mln equilibration period, all

tissues were exposed to 10 pM norepinephrine (NE) challenge as this allowed
subsequent responses of the tissue to be more consistent.

An additional washout and

re-equilibration period (45 min) preceded further exposure to contractile agents.

The

buffer in the organ baths was replaced with pre-waimed PSS every 15-20 min during
the course of the experiments.

Contractile agents and antagonists were applied in 10-

25 pi volumes of solvent using Eppendorf digital pipettes. Cumulative concentrationeffect curves (C-E curves, van Rossum, 1963) to contractile agents were constructed
by their addition to each organ bath in approximately 0.5 log unit increments to the
final concentrations indicated.

Assessment of the Denervation Procedure
The success of the denervation procedure was determined in vitro by the use of
tyramine which is able to enter intact adrenergic nerve terminals and elicit a
contractile response by causing the release of endogenous NE (Birmingham, 1970). In
the organ baths denervated and control vasa were exposed to 100 pM tyramine and
the contractile responses recorded. Only tissues producing 10% or less of the control
tyramine response were considered sufficiently denervated to be used in the study.

PKC_and_NonnaLContractile_EunctiQn
The role of PKC in the contractile activity of normal rat vas deferens was
studied using PKC activators and inhibitors to assess the extent to which these agents

28
would influence the contractile activity of the tissue. In most experiments exposure to
phorbol-12,13*diacetate (PDA), phorbol-12,13*dibutyrate (PDB), mezerein or 4aphorbol followed a 1 min pre-exposure of rat vas deferens to PSS containing 20 mM
K\

In each case that buffer concentrations of K* were increased, equivalent Na* was

removed to maintain osmolarity (see Appendix B for preparation).
Tissues were incubated with 30 nM nifedipine for 10 min or 30 jiM woH-7 for
20 min prior to agonist exposure. Paired vas deferens exposed to vehicle (ethanol or
distilled water, respectively) served as control for these experiments.

Modulation of

the NE response by PDA was studied by adding 2 pM of the agent to the tissue baths
10 min prior to the construction of concentration-effect curves for NE. Control NE
responses were elicited in the presence of the vehicle (0.1% DMSO, v/v).

PKC and DenervatioiLSuDersensitivitv
Contractile response to NE (single concentration or cumulative C-E curves, 10
nM-30 pM) were produced in denervated and control vasa to characterize the
supersensitivity that develops after chronic denervation of the tissue. Cumulative C-E
curves to neuroldnln A (NKA, 1 nM-3 pM) were also produced in pairs of control
and denervated tissues. The role of voltage-dependent calcium channels on the NE
response in denervated and control tissues was determined after treatment of both
groups of vasa with 100 nM nifedipine for 10 min. This concentration of nifedipine
was used since it was found to significantly antagonize the NE response without
abolishing it. The effect of direct PKC activation in denervated and control tissues
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was determined by producing contractile responses (cumulative C-E curves) to PDA in
both groups in PSS with 20 mM K* and 10 jiM phentolamine. Phentolamine was
used to antagonize the contractile response that could result from the release of
endogenous NE in adrenergic nerve terminals, especially in the control tissues. The
concentration of phentolamine used was sufficient to completely antagonize the
response to 10 pM NE applied exogenously.

Diacvl glycerol Production in the Rat Vas Deferens

Tissue Preparation
Whole vas deferens (denervated and control) were dissected from freshly kilted
rats and placed in cold, oxygenated PSS and cleaned of adhering connective tissue,
blood vessels and fat. Tissues were allowed to equilibrate under physiological
conditions in organ baths for about 1 hour before exposure to a 10

NE challenge.

This was followed by a 45 min washout and equilibration period before subsequent
exposure to 100 liM NE for 0, 30, 60, 120, 300 and 600 s. At this time the
stimulation was terminated by quickly placing the tissue in liquid nitrogen.

Sample Preparation
Immediately following the freezing of the tissue with liquid nitrogen, it was
placed in a ground glass homogenizer containing 3 ml chloroform/methanol (2:1
vol/vol) which had been cooled to -10°C, The tissue was homogenized completely
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with rapid strokes and then the homogenate was pipetted out and placed in 20 ml
scintillation vials. The homogenizer was rinsed with 1 ml of the chloroform/methanol
mixture which was also pipetted out and added to the scintillation vial. Vials were
tightly capped and stored at -20°C until extraction and analysis (within two weeks).

Neutral Lipid Extraction
The lipids in the sample were extracted according to the Bligh and Dyer (1959)
technique. Into each scintillation vial 2 ml of chloroform/methanol (2:l,v/v) followed
by 4 ml methanol and 2.5 ml water were added. The vials were vottexed and
methanol was added drop-wise until the cloudy suspension became clear. Three ml
chloroform and 3 ml H20 were added, the vials vortexed and centrifuged at 800 X g
for about 1 min.

Separation of the mixture into an aqueous (above) and organic

(below) phase was achieved by centrifugation. The lower phase was carefully pipetted
into 10 ml tubes and the upper phase was re-extracted with 3 ml of chloroform which
was also pipetted out after further centrifugation. The lipids of interest were
extracted into the chloroform layer which was then dried under a stream of nitrogen
with repeated rinsing of the tubes with chloroform to concentrate the lipids at the
bottom of the tube.

Once all the solvent was removed 200 pi of chloroform was

added to each sample. Tubes were tightly capped and stored at -20°C or samples
were immediately spotted onto thin layer chromatography (TLC) plates.
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Thin Laver Chromatography
Silica gel O plates (20 X 20 cm, Analtech Inc., Newark, DE.) were activated at
70°C for at least an hour before use. The plates were channelled with lanes of 1 cm
width and only the middle 18 lanes were used.

Chromatography tanks were prepared

by equilibrating them with 100 ml of hexane/diethyl ether/acetic acid (20:80:1, v/v/v)
for about 1 hour before use.

Known amounts of cholesterol and 1,2-dipaImitoyI

glycerol standards (0.4 - 10 pg), dissolved in chloroform, were applied to each plate.
Five and 50 pi of each sample in chloroform were applied to the TLC plate
using disposable glass mlcrocapillaiy plpets (Fisherbrarufi, lusher Scientific,
Pittsburgh, PA.). The plates were placed in the developing tank until the solvent front
traveled about 14 cm (in about 30-40 min). Plates were air dried and then sprayed
with 10% copper sulfate in 10% phosphoric acid and allowed to dry further. Lipids
were visualized by charring the plates over a hot plate (Thermolyne, Dubuque, Iowa)
which had been warmed to setting 6 for at least 10 min prior to use.

Analvsis_and_QuantificationoLLipids.
Charred TLC plates were scanned by a Howtek 3+ Digital scanner and the
image was recorded and analyzed by using Bio-Image (Millipore, Milford, MA.)
image analysis system on a SUN workstation. Density profiles for each spot on the
plate were produced, from which the integrated optical density was obtained. The
amount of tissue lipids (cholesterol and DAO) were determined from the standard
curve obtained by plotting the mass of cholesterol or dipalmitin (0.4-10pg) against the
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integrated optical density obtained for these standards. GraphPad's InPIot (San Diego,
CA.) curve fitting program was used to produce the standard curves from which the
mass of the sample DAO and cholesterol could be determined. The amount of
diacylglycerol in each tissue sample was then corrected for recovery rate of extraction
and variation in tissue weight simply by dividing the mass of DAG by the cholesterol
mass in the same sample. This could be done since cholesterol mass remains quite
stable and is proportional to the number of cells in the tissue, and thus the tissue mass
(Datta, 1987). The final data were expressed as ng DAG/pg cholesterol for each
tissue sample.

Molecular species of DAG_bv_HPLC

Sample Preparation. The molecular species of DAG that resulted from receptor
activation in denervated and control tissues were resolved by reverse-phase HPLC.
Three previously extracted neutral lipids samples from denervated and control vasa,
stimulated with 100 pM NG for 0 ,6 0 and 300 s, were pooled and then dried under a
stream of nitrogen. Hie lipids were dissolved in 300 pi of chloroform, spotted on
TLC plates and resolved in the hexane/diethyl ether/acetic acid system along with the
appropriate standards.
The DAG spots on the plates were visualized by spraying the plates with 0.5%
dichloroflouresceln (in ethanol) with the stain being enhanced by holding the plate in a
tank of ammonia. The silica gel containing the DAG spots was scrapped off the plate
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and placed in 10 ml tubes containing 2 ml ethanol (95%). Two ml of hexane and 2
ml of water were added to the tubes which were vortexed and then centrifuged at 800
X g for 30 s. The upper hexane layer was carefully pipetted out and placed in a
second 10 ml tube. The lipid mixture contained in the silica gel was re-extracted by
repeating the same process twice with 2 ml of hexane. The hexane containing the
sample lipids was dried off under nitrogen with repeated rinsing of the walls of each
tube to isolate the lipids at the bottom.

Benzovlation Procedure. Sample DAGs were converted to the benzoyl
derivatives before separation by HPLC. To each tube 100 pi of benzene, 20 pi of
benzoic anhydride (50 mg/ml, in benzene) and 10 pi of dimethyl aminopyridine (40
mg/ml, in benzene) were added. The tubes were shaken, flushed with nitrogen, tightly
capped and allowed to sit at room temperature for about 24 hours. At that time 200
pi of ammonium hydroxide was added to each tube to stop the reaction. Ten minutes
later 2.5 ml acetonitrile, 0.5 ml water and 3 ml hexane were added to the tubes
followed by vortexing and centrifugation to separate the organic and aqueous layers.
The upper hexane layer was pipetted into a second tube and the contents of the first
tube were re-extracted twice with 3 ml of hexane. The tubes were dried under
nitrogen stream with frequent rinsing of the walls, and the lipid at the bottom was
dissolved in 100 pi of acetonitrile/isopropanol (70:30, v/v).

Reverse-phase HPLC. The various species of diacylglycerol were resolved by
reverse-phase HPLC using an Ultrasphere-ODS column (Altex, Berkeley, CA., 4.5 X
250 mm) and mobile phase of ac et oni tri 1e/isopropanol (70:30, v/v) at 35°C. The
mobile phase flow rate of 1.4 ml/min was generated by a Peridn-Elmer Series 410 LC
pump and DAO derivatives detected by a Perkin-Elmer LC-95 UV/visible
spectrophotometer with absorbance at 230 nm. For data collection the detector was
interfaced to Maxima 820 chromatography workstation (Dynamic Solutions, Millipore,
Milford, MA.) by which the resulting chromatograms were stored for later analysis.
Molecular species of DAO in the sample were compared to known species that had
been previously derivatized to the benzoyl form. The standard mix of DAO
derivatives that were resolved by HPLC contained 1,2-dimyristoyl glycerol (14:014:0), 1,2-dipentanodecyl glycerol (15:0-15:0), 1,2-dioleoyl glycerol (18:1-18:1), 1paImitoyl-2-oleoyl glycerol( 16:0-18:1), 1,2-dipalmitoyl glycerol (16:0-16:0), 1-stearoyl2-oleoyl glycerol (18:0-18:1), 1,2-dtstearoyl glycerol (18:0-18:0) and l-steatoyl-2arachidonyl glycerol (18:0-20:4).

DAO Mass bv High-Pressure Liquid Chromatography

Sample Preparation. Tissues and samples were prepared essentially as
indicated for determining DAO mass by thin layer chromatography with minor
changes. Control vasa were exposed to 10 pM NE for 0-10 min under physiological
conditions and then rapidly frozen in liquid nitrogen. Whole tissues were then placed
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in scintillation vials containing 3 ml of chloroform/methanol (2:1 v/v) while stilt
frozen and stored at -20°C until the extraction procedure (usually 1 week later). fH]
cholesterol (200,000 dpm) and [3H] dipalmitin (10,133 dpm) were added to each
scintillation vial before the neutral lipid extraction procedure outlined above (Bligh
and Dyer, 1959), was undertaken. The radiolabelled lipids were eventually used to
estimate the recovery of sample lipids from the vials.

Column Fractionation. The extracted lipids were dried under nitrogen and
dissolved in 500 pi of hexane/methyl-tert-butyl ether (96:4, v/v) in preparation for
column fractionation, A Fisher Prep-Sep Si (300 mg) column was conditioned by
rinsing with 10 ml isopropanol, followed by 2 X 5 ml methyl-tert-butyl ether (MTBE)
and then 2 X 10 ml of hexane. All of the extracted lipid samples were applied to the
column and the tubes containing the lipid samples were rinsed with two further
aliquots (500 |il) of hexane/MTBE which were also applied to the column. Each 500
pi aliquot of sample was allowed to enter the column and then rinsed with 2 X 2 ml
of hexane/MTBE (96:4) to elute triglycerides and cholesterol esters in the sample.
The columns were then rinsed with 2 X 1.5 ml of hexane/MTBE/acetic acid
(100:2:0.2, v/v/v) to remove fatty acids. Cholesterol, diacyl- and monoacylglycetols
(MAG) were eluted from the column by 2 X 3 ml of MTBE/acetic acid (100:0.2) and
collected in 10 ml tubes. The solvent was evaporated under nitrogen with repeated
washings using chloroform to isolate the lipid sample at the bottom of the tubes.
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Lipid Separation and Quantification by HPLC. The isolated cholesterol, DAG
and MAG were benzoylated and collected just as described above for DAG from the
TLC extract. The benzoylated derivatives were then dissolved in 100 ill of 3.2%
MTBE in cyclopentane (v/v). The lipid components were then resolved by normalphase HPLC using an Ultrasphere SI column (Altex, Berkeley, CA.) in a mobile phase
of 3.2% MTBE in cyclopentane (v/v) at a flow rate of 1.0 ml/min and 35CC.
The lipids that eluted from the column were detected by a Perkin-Elmer LC-95
UV/visible spectrophotometer with absorbance set at 230 nm. The resulting
chromatograms were stored onto the hard disk drive of a NEC APC IV personal
computer by the use a Maxima 820 chromatography workstation. The cholesterol
fraction that eluted from the column was collected in 10 ml tubes while the DAG that
eluted was collected in 20 ml scintillation vials.
The cholesterol fraction was dried under nitrogen and dissolved in 400 pi
acetonitrile/isopropanol (63:37, v/v). About 20 pi of this sample was then resolved by
reverse-phase HPLC using an Ultrasphere-ODS column, acetonitrile/isopropanol
(63:37) mobile phase and 1.4 ml/min flow rate. The chromatograms were stored on
disk for further analysis and the cholesterol fraction eluting from the column was
collected in a second set of scintillation vials.
Scintillation vials containing the earlier collected DAG and the later cholesterol
were dried under nitrogen and the lipids were dissolved in 200 pi methanol. Ten ml
of scintillation cocktail were added to the vials before radioactivity determination in a
liquid scintillation counter (LS 6800, Beckman Instruments, Irvine CA,). The counts
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in each sample were a measure of the recovery rate of cholesterol and DAG from each
sample. The area under the peaks corresponding to cholesterol, DAG and MAG were
calculated using Maxima's peak integrating function. Using the peak area and
correcting for the recovery of lipid in each sample, the amount of cholesterol, DAG
and MAG in each sample was determined in volt*second. Using the molar
absorptivity of 13,200/M*cm for the benzoyl ester (Wame and Robinson, 1991) and
conversion factor 802140 pV*s/nmol for normal-phase (DAG and MAG) and 572957
pV* s/nmol for reverse-phase chromatograms (cholesterol), the lipid mass was
determined in nmoles. The conversion factors were determined by chromatography of
known amounts of 1,2-[3H]dipalmitoylglycerobenzoate and pHJchoIesteryl benzoate
and lipid mass verified by scintillation counting. The amount of DAG and MAG was
then normalized to the amount of cholesterol in each sample to account for differing
mass of tissue, with the final data being represented as nmol DAG or MAG/pmol of
cholesterol.

Binding Studies in the Rat Vas Deferens

Xissuc-and_SampiC-Prcparation
Freshly dissected vasa from animals seven days after surgery were placed in
ice-cold, oxygenated PSS and cleaned of connective tissue and attached blood vessels.
Denervated and control vas deferens were mounted in isolated organ baths, bathed in
oxygenated PSS and under 250-300 mg of tension. After about an hour of
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equilibration, each tissue was exposed to 100 pM tyramine to verify successful
denervation of the experimental tissues. Denervated vasa that did not respond to
tyramine were exposed to 10 pM NG and then all tissues were washed with fresh PSS
and incubated for a further 45 min.
Each vasa was placed in a ground glass homogenizer and manually
homogenized in 2.5 ml of ice-cold 25 mM MOPS buffer containing 250 mM sucrose,
2,5 mM EDTA, 2 mM EGTA, 10 mM fl-mercaptoethanol, 5 mM dithiothreitol and 10
pg/ml leupeptin. The homogenate was transferred to 15 ml polycarbonate tubes and
centrifuged in a Beckman J2-21M centrifuge (Beckman Instruments, Irvine, CA) at
50,000 X g for 30 min. The resulting supernatant was discarded and the pellet
resuspended in 5 ml of MOPS buffer (containing 5 mM CaCl2 and 8 mM MgCl2)
using a Kontes microtip sonicator/cell disrupter (Electro-Mech Instruments, Perkasie,
PA,), The suspension was centrifuged a second time at 50,000 X g for 30 min and the
supernatant was discarded. The pellet was resuspended in 3 ml of 25 mM MOPS
buffer (5 mM CaQj, 8 mM MgG2, pH 7.4 at 37°C) using a sonicator and then either
kept on ice until the binding assay was performed or stored at -20°C for up to 2 weeks
before assay.

Binding Assay Procedure

Protein Assay. Aliquots (100 pi) of the membrane samples in MOPS buffer
were assayed for protein content using a modified procedure of the method introduced
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by Lowiy et al. (1951, see Appendix C) and using bovine serum albumin as the
protein standard.

Saturation Binding Assay. The binding characteristics of membrane-bound
protein kinase C from denervated and control samples were compared using the
pHJphorbol dibutyrate binding assay. The assay was done in 1.5 ml microcentrifuge
tubes at 37°C in a shaking incubator/water bath (Precision Instruments, Chicago, IL.).
Each microfuge tube contained 0.1 - 80 nM of pH] phorbol dibutyrate ([3H]PDB,
diluted from the stock in MOPS buffer) and 50 - 150 pg of protein sample (in MOPS)
in 250 pi total volume. On occasion 10 pM of mezerein (a non-phorbol PKC
activator) was present in each tube to account for non-specific binding of the ligand.
The microfuge tubes were incubated in the water bath for 20 min at 37°C and pH 7.4,
with constant agitation.
At the end of the incubation period, the tubes were quickly removed from the
incubator and placed in a microcentrifuge. The tubes were centrifuged at 16,800 X g
for 15 min to separate free and bound ligand. An aliquot of the supernatant (100 pi)
was pipetted Into 20 ml scintillation vials and counted to determine the free
concentration of the pH]PDB. The rest of the supernatant was pipetted out and
discarded into appropriate storage containers. The tip of each microfuge tube
containing the membrane pellet was cut into a 20 ml scintillation vial using a sharp
blade. The pellet was treated with 200 pi of 0.5 N sodium hydroxide in 0,5% sodium
lauryl sulfate for about 30 min to digest the pellet protein, Bio-Safe n scintillation
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cocktail (10 ml) was added to the vials which were then allowed to sit overnight
before the radioactivity was determined. Vials were counted for 10 min each in a
Beckman LS 9800 scintillation counter (Beckman Instruments, Irvine, CA.) at 35-41%
efficiency.

Competitive Binding Assay. The binding characteristics of unlabelled PDA,
PDB, mezerein and 4cc-phorbol in control vasa were determined by competitive
binding of these agents with pHJPDB. As with the procedure outlined above, the
assay was performed in 1.5 ml mlcTofuge tubes in 250 pi MOPS buffer with 50-150
pg protein and 5-10 nM of pHJPDB, Various concentrations of PDA (1-10000 nM),
PDB (0.1-3000 nM), mezerein (0.1-3000 nM) and 4a-phorbol (0.1-300 pM) were
added to each tube. Tubes were incubated for 20 min at 37°C and pH 7.4 in a shaking
incubator. Bound and free ligand were separated by centrifugation as indicated above
and the radioactivity was determined by liquid scintillation counting.

Protein Kinase C Activity in Rat Vas Deferens

Tissue and Sample Preparation
Denervated and control vasa were prepared and incubated in PSS as outlined
previously. To determine differences in the ability of a-adrenoceptor stimulation to
activate PKC, each tissue was exposed to 100 pM NE. The tissues were stimulated
with NE for 0, 1 ,2 ,5 , and 20 min at which time they were quickly blotted on tissue
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paper and manually homogenized in a ground glass apparatus containing ice-cold
buffer. The volume of homogenizing buffer used for each tissue was 50 volumes of
the tissue wet weight, and consisted of 25 mM MOPS (pH 7.4 at 25°C) 250 mM
sucrose, 2.5 mM EDTA, 2 mM EGTA, 10 mM P-mercaptoethanol, 5 mM DTT, 1
mM phenylmethylsulfonyl fluoride and 5 pg/ml leupeptin.
The homogenate was centrifuged at 50,000 X g for 30 min at 4CC and the
supernatant (cytosolic fraction) was pipetted out and stored in capped 5 ml
polypropylene tubes at -20°C. The pellet was resuspended in 4 ml of homogenizing
buffer using a Kontes micro-ultrasonic cell disrupter (Electro-Mech Instrument Co.,
Perkasie, PA). The suspension was also stored frozen until the assay procedure (2
weeks later). On the day of the assay, the samples were thawed at room temperature
and kept on ice.
The pellet suspension was treated with Triton X-100 (0.3% final concentration)
for about an hour, while on Ice, with intermittent mixing using a sonlcator. The
mixture was then centrifuged at 50,000 X g and 4°C for 30 min. The supernatant
containing the solubilized membrane proteins was saved as the particulate fraction and
kept on ice. The particulate and cytosolic fractions (100 pi aliquots) were then
assayed for protein content using the Bio-Rad protein assay reagent (Bio-Rad
Laboratories, Hercules, CA.) with bovine-Y-globulin as the protein standard (Appendix
D). Hie samples were all diluted with the homogenizing MOPS buffer to a final
protein concentration of 40 pg/ml before assaying for PKC activity.
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Protein.Kinase_CActivitv_Assav
The paniculate and cytosolic cell fractions were assayed for PKC activity using
a commercially available kit from Amersham. The assay detects the ability of sample
PKC to transfer the labelled phosphate group from [y-3IP!ATP onto a threonine
residue on the peptide substrate in the presence of optimal concentrations of calcium,
phosphatidylserine and phorbol myristate acetate (PMA). The peptide substrate is
derived from the epidermal growth factor (EGF) receptor which has been shown to be
directly phosphorylated by PKC during cell activation with EGF (Heasley et al., 1989).
Twenty five pi of each diluted sample (1 pg protein content) was incubated with [y” P]ATP (22,000 dpm), 75 pM substrate peptide, lmM calcium acetate, 3.75 mM
magnesium acetate, 2 pg/ml phorbol 12-myristate 13-acetate (PKC activator) and L-ophosphatidyl-L-serine in 75 pi total volume. The reaction tubes were incubated at
25°C for 15 min and the reaction stopped with the addition of 100 pi dilute acid. An
aliquot from each tube (125 pi) was spotted onto a 4 cm1 piece of peptide-binding
paper which was then rinsed twice in 5% acetic acid (10 ml/paper) for 10 min. The
papers were then placed in 20 ml scintillation vials along with 10 ml Bio-Safe n
cocktail. The vials were capped and counted without delay for 32P for 10 min each on
a Beckman LS 9800 counter (Irvine, CA.). Blank runs with no protein sample were
performed simultaneously to account for nonspecific binding of radioactivity to the
binding papers. Eight particulate and cytosolic samples from the two groups were
randomly chosen and assayed for PKC in the absence of Ca2\ PMA and PS. This was
to determine nonspecific kinase activity in the samples.
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Calculations and Statistics

Contractl!e_Studies
Data are usually represented by the mean (± S.E.M.) response as a percent of
the paired, control response, for 3-7 animals.

This method of data representation

decreased the variation between animals and allowed for more rigorous comparisons.
The one- and two-way analysis of variance with least significant difference (LSD)
were used to compare mean responses. Bonferroni's multiple comparison test was
applied to analyses that resulted in nonsignificant F-ratios. The Students t-test was
only used when the variation of the means were equivalent for the two groups being
compared. Levels of P < 0.05 were accepted as indicative of significant differences
between the groups being compared. Statistical analyses were done on an IBMcompatible personal computer using the SPSS/PC* Studentware (SPSS Inc., Chicago,
IL .) or InStat (San Diego, CA.) software packages.

Diacvlglvcerol Studies
The mass of DAG and MAG were expressed in terms of the cholesterol content
of each sample to account for differences in lipid recovery after the extraction
procedure as well as to normalize for the differing mass of the tissues. The mean ±
S.E.M. or S.D. of these values were used to represent the data. Data were not reduced
to percent values in order to allow for comparisons with further experiments. One
way analysis of variance (InStat software, San Diego, CA.) was used to compare
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means and probability values less than 0.05 were accepted as indicating statistical
difference.

PHIPDB Binding Studies
Data obtained from the radioligand binding assays were converted from counts
per minute to picomoles of binding per milligram of protein by using a spreadsheet
program (SwiftCalc, Northbrook, IL.) on a personal computer. In the saturation
binding assay these values were then used to determine the binding maximum (B^,,)
and dissociation constant (K4) of [3H]PDB in the protein samples obtained from
denervated and control vasa. Using the non-linear regression analysis available on
GraphPad InPlot software (San Diego, CA.), the data were fit to the equation:

Total Binding » | ^ J L?gan^ , + N [Ligand],
Kd+ [Ligand]

where N» [Ligand] represents the nonspecific binding of the ligand. The B ^ ,
represents the maximum number of binding sites in pmoles per mg protein whereas
the Kd is the dissociation constant of [3H]PDB for the binding site in nanomolar.
In the competitive binding studies the data were reduced to percent of maximal
binding for each of the unlabelled ligands. These values were fit to the competitive
binding equation for one or two sites using GraphPad's curve fitting program. The Kd
for the competing ligands were calculated by converting the ICjo using the Cheng and
Pnisoff (1973) factor.
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K =
1

IC«
j + [Ligand] ’
Kd

where Kj is the dissociation constant of the competing unlabelled compound, and Kd is
that of [1H]PDB and [Ligand] is the concentration of the pH]PDB. This analysis was
also performed using GraphPad InPlot. The mean values of B ^ , and Kd (± S.E.M.)
obtained for the denervated and control samples were compared by paired Student's ttest, with P < 0.05 as indication of statistical difference.

PKC Activity in Vas Deferens
The efficiency of 3JP counting was assumed to be 100% and counts per minute
were converted to nmoles of phosphate transferred to the peptide substrate per min per
mg of sample protein (nmol/min/mg), according to instructions available with the kit.
These values from each of the 4 tissues (animals) in each treatment group were
averaged (mean ± S.G.M.). Using one-way analysis of variance changes in PKC
activity in particulate and cytosolic fractions after agonist stimulation were compared
to basal activities in resting tissues. Changes in corresponding denervated and control
tissue PKC activities after agonist stimulation were also compared by analysis of
variance. Probability values less than 0.05 were accepted as indicating significant
differences between the means under comparison.
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Materials and chemicals

Contractile Studies
(-)-Norepinephrine bitartrate, l-oleoyl-2-acetyl-sn-glycerol (OAO), PDA, PDB,
mezerein, 4 a-phorbol, nifedipine, and l-(5-isoquinolinylsulfonyl)-3-methylpiperazine
(isoH-7) were obtained from Sigma Chemical Co, (St. Louis, MO.).

Neurokinin A

(NKA) was purchased from Bachem California, Inc. (Torrance, CA.) and phentolamine
was a kind gift from Ciba-Geigy (Summit, NJ,).

PDA, PDB, mezerein and 4 a-

phorbol were dissolved in DMSO and chloroform was the solvent for OAG.
Nifedipine was initially dissolved in ethanol and dilutions were made In distilled
water.

Final concentration of solvents in the organ baths did not exceed 0,1% (v/v).

All other agents were dissolved in distilled water or PSS before addition to organ
baths,

Reagents and chemicals were obtained from Fisher Scientific (Pittsburgh,

PA.).

DAG Studies
Methanol, chloroform, hexane, methyl-tert-butyl ether and cyclopentane were of
HPLC grade and purchased from Burdick and Jackson (Muskegon, MI.). Benzene,
benzoic anhydride, benzoyl chloride and pyridine were from Aldrich Chemical Co.
(Milwaukee, WI.). (1^-JH(N)) Cholesterol (62,0 Ci/mmol) was from New England
Nuclear (Boston MA.) while the pH] dihexadecanoyl-sn-glycerol (fH] dipalmitin) was
prepared from L-a-dipalmitoyl [2-9,10-3H(N)]phosphatidylcholine (50.0 Ci/mmol,
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NEN) by phospholipase C (Bacillus cereus, Type Xmt Sigma Chem. Co., St. Louis,
MO.) hydrolysis (Wame and Robinson, 1991). 1,2-diecylglycerol standards were
purchased from Sigma or prepared by phospholipase C hydrolysis of the appropriate
phosphatidylcholine species (Sigma Chem. Co.) as described above.

Binding Studies
3-(N-morpholino) propane sulfonic acid (MOPS), EDTA, EGTA, leupeptin, 0mercaptoethanol and dithiothreitol were obtained from Sigma Chem. Co. (St. Louis,
MO.). [20-3H(N)l Phorbol-12,13-dibutyrate (18-20 Ci/mmol) was purchased from
New England Nuclear (Boston, MA.). Bio-Safe II scintillation cocktail was from
Research Products International (Mount Prospect, IL.) and all other chemicals and
reagents were from Fisher Scientific.

PKC_Activitv_Studies
The protein ldnase C kit and [y-3JP]ATP (3000 Ci/mmol) were purchased from
Amersham Life Sciences (Arlington Heights, IL.) whereas the Bio-Rad protein assay
was from Bio-Rad Labs (Hercules, CA.). The bovine-Y-globulin, EDTA, EGTA,
phenylmethyl5ulfonyl fluoride, DTT and leupeptin were from Sigma Chem. Co. (St.
Louis, MO.). All other chemicals and reagents were from Fisher Scientific.

CHAPTER 3
Results

Contractile Studies in the Vas Deferens

Normal Contractile function and PKC.
Exposure of the rat vas deferens to 10 pM NE caused a rapid increase in
contractile force that reached a maximum within 25-30 seconds and then decayed to a
steady tonic phase within 2-3 min (Fig. 3A).

Neurokinin A (NKA, 2 pM, not shown)

and K* (60 mM, Fig. 7) challenges also produced similar profiles.
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Figure 3 (A) Typical isometric response to 10 pM NE in the rat vas deferens. (B)
Response to 20 mM K*-PSS followed by 2 pM PDA in the same tissue. (C) Response
to 2 pM 4 a-phorbol in 20 mM K*-PSS. Resting tension on all tissues at the beginning
of the trace is 250 mg. *W' indicates tissue rinsed with fresh PSS.
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Exposure of vasa deferentia to PDA or PDB alone produced, at best, a small
transient contractile response (less than 10% of the maximal NE response).

However

In the presence of PSS containing 20 mM K \ 2 pM PDA produced a prompt phasic
response that was 87 ±0.1% (n-4) of the 10 pM NE response.

Contractile force was

maximal within 2 min (Fig. 3B) and then decayed to a sustained tonic phase (later
tonic response not shown).

By varying the Kf concentration of the PSS from 10-40

mM maximal PDA response was found to occur in PSS containing 20 mM K \
Phorbol-12,13-dibutyrate (2 pM) also elicited a contractile response that was 50 ± 2.8
% of the maximal NE response (n*<4; not shown) whereas the inactive, 4a-phorbol (2
pM), was unable to elicit any contractile response (Fig. 3Q.

The responses to PDA

(in the presence of 2 0 mM K*) were concentration-dependent with an EC*, of 190 ±
26 nM (n-4, Fig. 4).

lo o
75

[Phorbol d ia c e ta te ] (M)
Figure 4. Cumulative concentration-effect curve for PDA in 20 mM K*-PSS.
Each point represents the mean response (± S.E.M.) of four animals.
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Contractile responses to PDA and PDB were immediately reversed by rinsing
tissues with normal PSS and were attenuated by 20 min pretreatment with 30 pM
froH-7, a PKC inhibitor. Prior treatment of vas deferens with 30 nM nifedipine, a
dihydropyridine calcium channel blocker, resulted in greater than 80% decrease in the
PDA contractile response (P < 0.05, Table 1).

Neither chronic surgical denervation of

the vas deferens (Table 1) nor 10 pM phentolamine pretreatment (not shown) had an
effect on the maximal PDA response obtained in the 20 mM K*-containing PSS. The
DAG analog, OAG (10 pg/ml), did not produce a significant contraction (in normal or
20 mM K*-PSS) when compared to paired tissue exposed to the vehicle (chloroform,
not shown).
The contractile responses of the vas deferens to NE and NKA were noncompethlvely inhibited by pretreating vas deferens with 30 pM froH-7 for 20 min.
Maximal responses to NE and NKA were reduced to 42 and 30% of control (P <
0.005), respectively (Figs. 5 and 6 ). IsoW-1 also depressed maximal phasic responses
to 60 mM K* and 2 pM PDA (65 and 49% of control, respectively, P < 0.05). IsoH-1
treatment of rat vas deferens resulted in a marked loss in the sustained (tonic) response
to K* (Fig. 7) and PDA (not shown).

51

Table 1
The effect of various treatments on the 2 jiM PDA-induced (in 20 mM K*-P5S)
contractile response in the rat vas deferens.
One vas deferens was used as the control tissue while the paired tissue was either
chronically denervated, treated with 30 pM fcoH-7 (20 min) or treated with 30 nM
nifedipine (10 min) prior to eliciting the PDA response. Data are represented by the
mean (± S.E.M.) response of 4-6 animals, expressed as a percent of the control
response.

Conditions

n

Contractile response to PDA
in 20 mM K*-containing PSS
(% of the control response)

Paired control

4

100

7-day denervated

6

128.9 ± 17.8

After isoH-7

4

49.2 ± 6.0

After nifedipine

4

15.9 ± 3.3 b

1

•* Significantly different from control, P < 0.05 and P < 0.005, respectively.
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Figure 5. Cumulative C-E curve to NE in control and 30 liM isoU-7 treated rat
vas deferens. Data are the mean (± S.E.M.) response of three animals.
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Figure ti. Cumulative C-E curve for NKA in control and 30 nM isoH-7 treated
vas deferens. Data are the mean (± S.E.M.) response from four animals.
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Figure 7. Representative tracings of the contractile response to 60 mM K+ in
control (A) and 30 pM isoH*7 treated (B) vas deferens. Resting tension on the
tissues prior to stimulation was 250 mg.
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Vas deferens pretreated for 10 min with 2 pM PDA in normal PSS showed no
significant change in the onset of response or the EC*, of the subsequent NE
concentration-curve effect (Fig, 8 ). The maximal response to NE in the presence of
PDA was greater than with NE alone in every case but narrowly failed to achieve
statistical significance by two-way analysis of variance (P < 0.07) and Bonferroni's
test.

200

[Norepinephrine] (M)

Figure 8 . NE response after 10 min PDA (2 pM; • ) or vehicle (DMSO; O)
pietreatment of paired vas deferens. Responses are represented by the mean (±
S.E.M.) o f six animals, obtained in normal PSS.
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Assessment of Denervation. Vasa deferentia that were chronically denervated
and their paired controls were exposed to 100 pM tyramine in isolated organ baths
and the contractile response recorded. Denervated tissues showed a time-dependent
loss in responsiveness to tyramine (Fig. 9), with 2-day denervated tissues producing
21,8 ± 5.2% of the control response (n-4, P < 0.001). Vasa denervated for seven
days produced a contractile response that was 1.7 ± 0.7% of control (n**4, P < 0.001).
The tyramine response was essentially the same for tissues that were denervated for 414 days and only those producing 10% or less of the control were considered
sufficiently denervated to be used in the study.
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Figure 9. Tyramine response in control and paired! 2 or 7-day denervated rat vas
deferens. ** indicate significant difference from control (P < 0.001).
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NE response in denervated vas deferens. In tissues that were chronically
denervated for

6 -8

days, 10 pM NE was able to elicit 2,02 ± 0,3 g of contractile

tension within 25 seconds (Fig. 10). The paired control tissues produced 0.63 ± 0.11
g of maximal tension at the same time point (n- 6 , P < 0.005). All tissues that were
tested showed an initial large phasic response followed by a later tonic response of
lesser magnitude. The tonic poition in the denervated tissues was significantly greater
than that of control vas for up to 3 min of NE exposure (P < 0.05).
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Figure 10. Time-course of contractile force generated by denervated ( • ) and
control (O) vas in response to 10 pM NE. Response in the denervated vasa were
significantly greater than in controls at all points (P<0,05).
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Cumulative C-E curves to NE were produced in denervated tissues and
compared to control responses to characterize the increased sensitivity of these tissues.
The EQd for NE in denervated tissues was 5,5 X 10^ M while that in the control was
9 X 10*7 M, an 18-fold shift in the C-E curve after denervation (Fig, 11), Cumulative
additions of NE also resulted in 73.3 ± 8.7% greater contractile maximum in
denervated than in the control vas (P < 0.01), The contractile responses to NE in
denervated vasa were significantly greater than in the control at all concentrations of
the agonist tested (P < 0.01).
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Figure 11. Concentration-effect curve to NE in 7-day denervated and paired
control rat vas deferens. All denervated values were significantly different from
control (P < 0.05).
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Response to NKA in denervated vas deferens. Construction of cumulative C-E
curves to NKA in denervated and control vasa showed no significant alteration in the
threshold concentration or EC50 of the two groups (Fig. 12). Moreover, there was no
overall effect of denervation on the NKA response of the vas deferens as indicated by
two-way analysis of variance (P > 0.1). None of the concentrations of NKA used
produced a significantly greater response in the denervated tissue, as indicated
Bonferroni's multiple-comparison test.
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Figure 12. Neurokinin A contractile response in control (A ) and denervated
(*) rat vas deferens.
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Response to PDA in Denervated Vas Deferens. Cumulative additions of PDA
to isolated organ baths produced significant contractile responses in both the control
and denervated vas deferens (Fig. 13). In the presence of 10 pM phentolamine (an a adrenergic receptor antagonist) and 20 mM K*-PSS, PDA produced concentrationdependent contractile activity in both tissue groups. However the responses obtained
from ihe two groups were not significantly different. Contractile responses to single
challenges of 2 pM PDA (in 20 mM K‘) were not significantly altered after
denervation either (Table 1).
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Figure 13. Concentration-effect curve to PDA (20 mM K*-PSS) in denervated and
control vasa.
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NE response in denervated vasa after nifedipine. Concentration-effect curves to
NE were constructed in denervated and control tissues, before and after 10 min
incubation with 100 nM nifedipine (a calcium channel blocker), The response to NE
obtained after nifedipine was expressed as a percent of that before pretreatment with
the channel blocker (Fig. 14), This concentration of nifedipine was selected as it
significantly inhibited the contractile activity of both the denervated and control tissues
in response to NE (P < 0.05) without completely abolishing it. The maximal
contractile response to NE in the presence of nifedipine was 11.7 ± 1.0% (P < 0.001)
and 34.8 ± 2.3% (P < 0.001) of the response before, in control and denervated tissues,
respectively. Thus, nifedipine was able to inhibit

88%

of the NE response in control

vasa whereas only 65% of the denervated tissue response was antagonized.
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Figure 14. NE contractile response in denervated and control vas deferens before
and after 100 nM nifedipine treatment. Responses to NE after nifedipine treatment,
in each tissue, is expressed as a percent of the NE response before nifedipine
exposure.
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Determination of Diacvlclvcerol Mass in Rat Vas Deferens
DAG Mass bv Thin Laver Chromatography.
Denervated and control vasa were exposed to 100 pM NE in isolated organ
baths under physiological conditions, for up to 10 min. The neutral lipids in the tissue
were extracted in chloroform, and DAO and cholesterol resolved along with
appropriate standards by thin layer chromatography. The lipids were visualized by
charring on a hot plate (Plate 1) and quantified, relative to lipid standards, using BioImage analysis software.
The mass of DAG in each sample was divided by the mass of cholesterol in
the same sample and expressed as ng of DAG per pg of cholesterol. Exposure of
denervated and control vasa to 100 pM NE resulted in no significant change in free
DAG from basal values at any of the time points determined (Fig. IS). Additionally,
diacylglycerol mass was not significantly different between the two groups at any of
the time-points compared.
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Figure 15. Diacylglyceiol mass determined in denervated and control vas deferens
after stimulation with 100 |iM NE. Data are represented by the mean (± S.E.M.) for
3*4 animals.

Plate 1 Thin layer chromatographic plate containing the cholesterol (column 1-5) and
DAG (column 14-18) standards as well as lipid samples (column 6-13) from
denervated and control vas deferens treated with NE for 10 min. For each sample a
low and high amount were applied to the silica plate with the low amount being used
to quantify the cholesterol content and the high sample used to determine DAG mass.
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DAG Mass in Control Vas Deferens bv HPLC,
Control vas deferens alone were exposed to 10 nM NE for 0-10 min under
physiological conditions and the neutral lipids extracted from the tissue. DAG and
MAG were separated and quantified by normal-phase HPLC. The mass of DAG and
MAG were divided by the amount of cholesterol in the same sample and expressed as
nmol/nmol

cholesterol. Basal levels of DAG determined by HPLC

(35

nmol/(imol

cholesterol) were similar to those obtained by TLC (29 ng/jig cholesterol). As with
the TLC experiments stimulation with NE for up to 10 min did not significantly alter
the mass of DAG in the tissues (Fig. 16). The mass of MAG in the same samples did
not accumulate significantly until after
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Figure 16. DAG ( • ) and MAG (O) levels in control vas after NE exposure. Lipid
mass was determined by HPLC from 2 animals at each point.
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Molecular Species of DAG in Rat Vas Deferens.
The molecular species of DAG from denervated and paired control vasa were
compared by reverse-phase HPLC to reveal any alteration in the source of DAG
following denervation. Species of DAG from denervated and control vas deferens
stimulated with 100 pM NE for 0, 1 and 10 min were compared.
All samples contained DAG lipids with similar retention times as the 18:0-18:1,
16:0-16:0, 16:0-18:1, 18:1-18:1 and 18:0-20:4 DAG standards (Fig. 17). Exposure to
NE for 10 min resulted in relatively higher amounts of the 18:0-20:4 DAG species in
both control and denervated tissues. Chronic denervation of the vas deferens did not
alter the relative amounts of the various species of DAG in resting or NE stimulated
tissues (not shown).

Unstimulated
NE <10 min)

.09
.08
.07 0

5

10

15
20
Time (min)

25

30

Figure 17. Molecular species of DAG from resting and NE stimulated (10 min),
denervated rat vas deferens; separated by reverse-phase HPLC, The arrow indicates
the position of 18:0-20:4 DAG.
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r’HlPhorboLDihutvrate Binding Studies

r3H1PPB Binding in Control Vas Deferens.

Control vasa were homogenized in 0.3 mM CaClj/1 mM MgCl2-containing
MOPS and the particulate fraction (containing the plasma membrane) was assayed for
PKC binding characteristics. The specific binding of the ligand was calculated from
total binding by non-linear regression analysis (GraphPad InPIot, Fig. 18). A binding
maximum ( B ^ ) of 22.8 pmol/mg protein and dissociation constant (Kd) of 7.6 nM
were obtained. Binding assays performed in the presence of 10 pM mezerein (to
account for nonspecific binding) provided a B ^ of 27.9 pmol/mg and Kd of 9.8 nM.
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Figure 18. Specific binding o f ^HIPDB to control rat vas deferens particulate
calculated from total binding. Each data point is a mean of 2 replicates.
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Specific binding of [3H]PDB was competitively displaced by unlabelled
mezereln (Kd - 7 nM), PDB (Kd - 15 nM) and PDA (Kd - 500 nM) but not by the
non-PKC activator, 4a-phorbol (Fig, 19).
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Figure 19. Competitive binding of mezerein (mez), PDB and PDA but not 4 a phorbol with pHJPDB, in control vas deferens.

PHIPDB Binding in Denervated Vas Deferens.
Control and paired, denervated vas deferens were prepared as indicated earlier
and homogenized in Ca2*-free MOPS containing EDTA and GGTA. The particulate
fraction was isolated and assayed. As indicated above, specific binding was calculated
from total binding by non-linear curve fitting. The B ^ obtained from control and
denervated samples were 4.8 ± 0.9 pmol/mg and 4.1 ± 0.4 pmol/mg of protein,
respectively. The Kd values obtained from the two groups were also similar (Table 2),
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Table 2
Specific binding of []H]PDB in control and denervated rat vas deferens.
Whole rat vas deferens (denervated and paired control) were cleaned of extraneous
tissue, incubated in PSS for 45 min and then challenged with 10 pM f4E. After
thorough rinsing and a further equilibration period, all tissues were homogenized in
2.5 ml MOPS containing 2.5 mM EDTA and 2 mM EGTA. The particulate
fractions of the homogenates were isolated and pHJPDB binding assays performed
on them.

Tissue Sample
(n)

Bmu (± S.E.M.)
(pmol/mg protein)

Kd (± S.E.M.)
(nM)

CONTROL
4

4.8 ± 0.9

4.3 ± 0.6

DENERVATED
4

4.1 ± 0.4

3.5 ± 0.1
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Protein Kinase C Activity in Rnt Vas Deferens
PKC activity in controi tissues.
Brain PKC activity has been characterized extensively (Nishizuka, 1988) and
therefore initial studies were conducted to compare the relative amounts of PKC in the
vas deferens. Samples of rat brain striatum and vas deferens were cleaned in cold,
oxygenated PSS and incubated in Ca2*-free (EDTA/EGTA) MOPS buffer for 15 min.
The tissues were homogenized in Ca^-free MOPS and particulate and cytosolic
fractions were prepared. All samples were assayed for protein content and diluted to a
concentration of 40 pg/ml before being assayed for PKC activity.
Protein kinase C activity in the brain cytosolic fraction was 16.3 ± 1.1
nmol/min/mg protein (n»3) whereas that in the particulate was 5.6 ± 0.2
nmol/min/mg (n- 3 ), giving a cytosolic to particulate ratio of 2.9. The PKC activity
was 10.9 ± 0.3 and 5.3 ± 0.4 nmol/min/mg protein (n**4) in the vas cytosolic and
particulate samples, respectively. This provided a cytosolic to particulate activity ratio
of 2.1 in the vas deferens. The cytosolic activity of PKC in the brain sample was
significantly higher than in vas deferens (P < 0.05) but particulate activities were
equivalent.

Effect of denervation on NE-induced PKC activation.
Whole vasa deferentia (paired control and denervated) were prepared as
indicated previously, incubated under physiological conditions and stimulated with

100

pM NE for 0-20 min. At various time-polnts of stimulation the tissues were quickly
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blotted on tissue paper and then homogenized in Ca2f-free MOPS.
The homogenates were separated into cytosolic and particulate fractions by
centrifugation and following protein assay were diluted to 40 pg/ml of protein. The
samples were assayed for total PKC activity as indicated earlier. Eight samples
randomly selected from the particulate and cytosolic fractions were also assayed for
activity In the absence of Ca2\ PMA and PS to determine the extent of 'nonspecific'
phosphorylation activity in the assay.
Basal PKC activity of particulate and cytosolic fractions from denervated and
control tissues were not significantly different. Stimulation of both denervated and
control vasa with ME resulted in a time-dependent increase in particulate PKC activity
with a concomitant decrease in cytosolic activity (Fig. 20 and 21).
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Figure 20. Effect of NE exposure on PKC distribution in control vas deferens.
Each point is the mean (± S.E.M.) of 4 rats and * indicates significantly different
from 0 min activity (P < 0.05).
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Figure 21. Effect of NE on PKC distribution in denervated rat vas deferens
cytosolic and membrane fractions. Each point is the mean (± S.E.M.) of 4 animals.
* indicates significantly different from 0 min values (P < 0.05).
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In membrane preparations from control vasa, PKC activity was significantly
elevated by NG at 2, 5 and 20 min. The cytosolic activity of PKC from these tissues
were not significantly different ftom basal levels for up to 20 min of NE stimulation.
For denervated tissues the particulate activity was significantly greater than
basal values after 1,2, 5 and 20 min of NE stimulation (P < 0.05), and in the cytosolic
samples PKC activity was only significantly altered at the 1 min point (P < 0.05). The
maximal NE-induced PKC translocation to the membrane fraction was not different
between the two groups, However, the maximal change was evident in denervated
tissues within 5 min (Fig. 21) but was achieved only after 20 min in control samples
(Fig. 20). Membrane PKCactivity in the denervated vasa was different ftom that in
the paired control tissue at 2, 5 and 20 min after NE stimulation (Fig. 22, P < 0,05).
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Figure 22. Time-course of PKC translocation to the membrane fraction of
denervated and control samples after NE treatment. * indicates values significantly
different from the paired control activity (P < 0.05).
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Cytosolic PKC activity was not different between the two groups at any of the
time-points except

5

min, when difference in particulate activity between the two

groups was maximal as well (compare Figs. 18 and 19). Activity in the absence of
Ca2\ PMA and PS was 9.8 ± 0.5% and 21.9 ± 1.1% of total activity in particulate and
cytosolic fractions, respectively (n - 8 , significantly different, P < 0,005),

PKC activation bv other agents.
Particulate and cytosolic fractions from denervated and control vas deferens
were prepared afier stimulation with 60 mM K*-containing PSS, 2 pM NKA or 2 pM
PDB (in 20 mM K*-PSS). Treatment with each of these agents significantly increased
PKC activity in the particulate fractions of all the samples (P < 0.01, Table 3) without
significant alteration in cytosolic activity. Within each pair of denervated and control
sample there was no difference in the PKC activities in response to the various
agonists except that between cytosolic activity of PDB treated denervated and control
vasa (P < 0.05).
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Table 3
Effect of K*-depolarization, NKA and PDB on PKC distribution in denervated and
control rat vas deferens.
Denervated and control vasa were stimulated with 60 mM K*-PSS (for 2 min), 2
NKA (for 2 min) and 2 pM PDB (in 20 mM K*-PSS, for 3 min) and cytosolic and
particulate fractions prepared. Each of the fractions was assayed for PKC activity and
compared to values obtained from unstimulated tissue samples. The data are
represented by the mean (± S.E.M.) PKC activity of 3-4 animals (n).

Condition/Agonist

Cytosolic
(nmol/min/mg)

Particulate
(nmol/min/mg)

Denervated/None

6.15 ±0.24 (4)

4.29 ±0.17 (4)

Control/None

7.44 ±0.24 (4)

3.34 ±0.44 (4)

Denervated/K*

5.96 ±0.38 (4)

12,77±1.06 (4)'

Control/K*

6,40 ±0,31 (4)

14.18±0.88 (4)b

Denervated/NKA

6.20 ±0,24 (4)

11.22 ±0.72 (3)'

Control/NKA

6.14 ±0.34 (4)

12.11±0.37 (4)b

Denervated/PDB

5.52 ±0.54 (4)c

12.85 ±1.86 (3)*

Control/PDB

6.64 ±0.38 (4)

13.9U1.09 (4)b

■* Significantly different from denervated/unstimulated or control/unstimulated
values (P < 0.01), respectively.
c Significantly different from paired control tissues exposed to PDB (P < 0.05).

CHAPTER 4
Discussion

In the present study the role of protein kinase C (PKC) in mediating enhanced
contractile response to receptor stimulation was examined. This enzyme has been
shown to perform numerous cellular functions, including a role in the contractile
activity of smooth muscle. In the smooth muscle of blood vessels, PKC activation
results in contractile activity (Merkel et a l, 1991), whereas PKC inhibition antagonizes
the contractile response to receptor agonists (NE and angiotensin II; Shibata et al.,
1990), The enzyme has also been implicated in the enhanced contractile response of
blood vessels from spontaneously hypertensive rats (Turla and Webb, 1987; Bazan et
al., 1992). Chronic denervation of the rabbit iris smooth muscle has also been
associated with about 30% increase in cytosolic PKC activity (Akhtar and Abdel-Latif,
1986).
An enhanced role for PKC in denervation supersensitivity was tested by
comparing the contractile activities of a PKC activator (PDA) in denervated and
control vas deferens. The amounts of diacylglycerol (DAG, the endogenous activator
of PKC) produced in response to NE stimulation were also determined in control and
denervated vas deferens, The binding characteristics of membrane-bound PKC to
labelled PDB in denervated and control tissues were determined and an enzymatic
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method was employed to determine the ability of agonists to activate PKC in the two
tissue groups.

Contractile Studies in the Vas Deferens

Normal Contractile Function and PKC
Exposure of the rat vas deferens to PDA or PDB in noimal P5S produced
contractile response that varied from none to small and transient.

The reason for this

response may be that the resting concentration of intracellular calcium is below the
threshold for PKC activation by phorbol esters. The activation of PKC requires free
calcium and the phorbol esters or DAO appear to decrease the calcium requirement of
the enzyme (Howe and Abdel-Latif, 1988). However, if the calcium concentration is
below the threshold for this activation then the phorbol esters would be unable to
stimulate kinase activity. This may explain why phorbol esters (PDA, PDB) were able
to elicit significant contractile activity in the presence of depolarizing PSS (20 mM
K*) which would presumably elevate intracellular calcium concentrations. In vascular
smooth muscle phorbol esters alone are able to elicit a sustained response that may
take up to an hour to develop maximally (Shibata et al., 1990; Merkel et al., 1991).
In Ca3*-ftee, depolarizing Tyrode buffer (80 mM K*), Baraban et al. (1985) obtained
a contractile response of the vas deferens by addition of 1 mM Ca3* and 0.2 f M PDA.
Their results were obtained after prolonged exposure of rat vas deferens to nonphysiological conditions, i.e.

80 mM K \ 0 mM Ca3* and 32°C bath temperature.
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In this study, responses to PDA and PDB were elicited after brief pre-exposure
(1 min prior to phorbol agonists) to iso-osmolar PSS containing 20 mM K \

The

ECjo estimated from the PDA concentration-effect curve (190 nM) agrees with that
obtained by Baraban et al. (1985) and with the Kd for PDA binding to brain PKC
(Konig et al., 1985) i.e.t 140 and 45 nM, respectively.

As with receptor stimulated

events, PDA and PDB (in the presence of 20 mM K*) produced a rapid phasic and a
sustained tonic contractile response. This response was immediately reversed by
rinsing tissues with fresh buffer and may indicate a membrane site for phorbol ester
action.

PKC appears to play the central role in the response to PDA and PDB

because 4 a-phorbol, which is unable to activate PKC in vitro (Howe and Abdel-Latif,
1988), was without effect in normal or 20 mM K*-containing buffer.
Inhibition of the K* plus PDA response by nifedipine would support the idea
that K*-depolarization only augments the action of PDA by raising intracellular Ca3*
concentration.

It is also consistent with observations that phorbol esters only increase

the affinity of PKC for Ca3* (Castagna et al., 1982; Howe and Abdel-Latif, 1988).
The failure of phentolamine and chronic denervation to inhibit the K* plus PDA
response, indicates that neither a -adrenoceptor activation nor NE release from
adrenergic nerves is involved in this response.

It is unclear why OAO, a synthetic

DAO, was unable to elicit a response in the rat vas deferens.
poor distribution through intact tissue may be the reason.

Rapid metabolism and

PKC activation by OAO

has mostly been demonstrated in cell-free systems (Howe and Abdel-Latif, 1988) or in
dispersed cells (Kaibuchi et al., 1983).
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Pretreatment of the rat vas deferens with isoH-7 significantly inhibited
contractile responses to NE and NKA. This agent has been shown to noncompetitively inhibit PKC (Kischel et al., 1989; Ratz, 1990) presumably by interacting
with the ATP binding site on the regulatory subunit of the enzyme (Hidaka et al.,
1984). However, the inhibitory action of this compound on other cellular kinases (e.g.
MLCK) are not known and cannot be ruled out.
The application of isoH-7 markedly attenuated the maximal phasic and
subsequent tonic response to 60 mM K* in the rat vas deferens.

This result is

consistent with reports that high extracellular K* causes PKC translocation and
activation (Ho et al., 1988; Haller et al., 1990).

These responses are most likely

mediated by the influx of CaJf via voltage-dependent calcium channels and subsequent
rise in intracellular Ca2\

The ability of CaJ* to activate PKC in the presence of

phosphatidylserine alone (Howe and Abdel-Latif, 1988) and its ability to convert
membrane-associated PKC to the membrane-inserted form (Huang, 1989) would also
support the idea of PKC activation by high K \

It is unlikely that feoH-7 antagonizes

the K* response by inhibiting Caa* influx since Shibata et al.
al.

(1990) and Merkel et

(1991) reported no influence of &oH-7 on the KMnduced 45Ca influx in vascular

smooth muscle.
In normal buffer, 10 min pretreatment of the vas deferens with PDA resulted in
no change in the onset or ECj<, of subsequent NE-induced contractile responses.

The

maximal contractile force in response to NE was enhanced by PDA pretreatment in
each tissue tested, but the overall result was found to be statistically non-significant.
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This may indicate that the statistical analysis procedure used (Bonferroni's post-test for
multiple comparisons) was too stringent. In the rat vas deferens Baraban et al. (198S)
reported significant enhancement of the contractile response to a single NE (20 juM)
challenge by 2-3 min pretreatment with PDA, However, we were not able to
reproduce this result in our experiments using single NE challenges and similar
incubation times.

Denervation Supersensitivitv in the Vas Deferens
Vas deferens that were chronically denervated for 0 ,2 and 7 days showed a
time-dependent loss in tyramine-stimulated contractile response. This loss in tyramine
response is very similar to the time-dependent loss in NE content of the denervated
tissues (Kasuya et al., 1969; Rice et al., 1987) and consistent with the degeneration of
adrenergic nerve endings after chronic denervation (Gordon-Weeks and Gabella,
1977). Birmingham (1970) also reported similar loss in tyramine response after
denervation of the rat vas deferens.
Chronic denervation of the vas deferens resulted in tissues that produced an
initial phasic and subsequent tonic contractile response to NE, much like the response
in control tissues. However, exposure of the tissue to a single concentration of NE
resulted in a maximal phasic response in denervated vasa that was 320% of the control
response. Since the time to maximal response was essentially the same in both
groups, the data would suggest a greatly increased rate of contractile force production
after denervation. Hie later tonic response to NE was also significantly greater in the
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denervated vas for up to 3 min of NE stimulation. The equivalent time to maximal
force after denervation also argues against the hypothesis that better diffusion of NE
through the tissue to the receptor sites is a factor mediating the supersensitivity
response (i.e. a prejunctional phenomenon).
Cumulative additions of NE revealed that denervated vasa were about 18-fold
more sensitive to the stimulatory action of the agonist when compared to control
tissues. The maximum force generated by cumulative NE addition was also
significantly greater in the denervated as compared to the control tissues. Much of the
decrease in threshold concentration for contraction in the denervated vasa appears to
be due to the loss of intact adrenergic nerve terminals.

This would result in greatly

reduced uptake of exogenously applied NE, resulting in higher effective concentrations
of NE at the receptor (prejunctional effect). This action may be demonstrated by
pretreating control vasa (having intact nerve endings) with NE uptake (cocaine and
hydrocortisone) and metabolism (U-0521) inhibitors before production of C-E curves
(Abraham and Rice, 1992a). The result is a 6 -fold decrease in the ECg, of the NE
response without a change in the maximal response.
The largest component of the shift in the NE curve after denervation would
thus be due to the loss in neuronal uptake of applied NE. The remaining 3-fold shift
in the denervated tissue response would be due to postjunctional alteration in tissue
response to the agonist. The enhanced maximal response to single concentrations, as
well as cumulative additions of NE, are consistent with the development of significant
postjunctional supersensitivity in the rat vas deferens.
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NKA Response in Denervated Vas Deferens
Neurokinin A, which produces a maximum contraction equivalent to NE in
normal vasa, did not reveal a significant increase in sensitivity of the tissue after
chronic denervation. Hie EC*, and maximal force developed were not significantly
different between denervated and control tissues, when compared by analysis of
variance. This lack of effect may reflect some basic difference in the coupling of the
neurokinin receptor (NK-2, Osakada et a l, 1986) to the contractile apparatus as
compared to the a-adrenoceptor. Thus denervation would result in enhanced coupling
of certain receptors (cc1( angiotensin and acetylcholine) but not others (NK-2), to the
contractile apparatus.
An alternate explanation for the lack of supersensitivity to NKA may be that
the cumulative additions of the agonists resulted in short-term desensitization of the
receptors. In this case non-cumulative exposures to NKA, with rinsing of tissues in
between additions, may more faithfully depict changes in response after denervation.
Support for short-term desensitization may be obtained from the NE response, where
the single challenge of NE produced a 320% greater response in denervated relative to
control tissues. The cumulative curve to NE only showed a 178% increase in maximal
response. However, any desensitization that may result from cumulative addition of
NKA would be short-term because the vas deferens is able to produce two very
similar NKA cumulative curves when separated by a 45 minute wash and equilibration
period.
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PDA Response in Denervated Vas Deferens
Phorbol diacetate (PDA) was able to elicit significant, concentration-dependent
contractile activity of the denervated rat vas deferens in 20 mM IC-PSS. However
this response to PDA was virtually identical to that obtained in the paired, control
vasa. Responses to single challenges of PDA (2 pM) were not significantly different
between the two groups.
The lack of an enhanced response in denervated tissues would indicate that
PKC activation by K* plus PDA is not significantly different in the two tissues. In
addition, this result would also argue against increased nexal contacts as mediating the
supersensitivity response, because this hypothesis predicts that all agonists will elicit
an enhanced response.

NE ResponseJn Denervated Vasa after Nifedipine
Cumulative C-E curves to NE were produced in control and denervated vas
deferens before and after treatment of the tissues with nifedipine. This treatment
eliminated about

88%

of the subsequent NE response in control tissues, whereas only

about 65% of the response in denervated vasa was abolished. These data are
consistent with control tissues being more dependent on extracellular Ca1* in producing
contractile tension, as compared with denervated tissues. The denervated tissues may
be more dependent on Cal * mobilized from intracellular sources via IPj-sensitive or
other mechanisms.
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These results do not exclude the possibility that the net cytoplasmic
concentrations of Ca3* are the same in the two tissue groups during receptor
stimulation, but that the contractile proteins become more sensitive to the cation after
denervation. Ramos et al. (1986) demonstrated that the denervated guinea pig vas
deferens was more sensitive to the rise in cytosolic Ca3f than control vasa. In Tritonx100-permeabilized guinea pig vasa, cumulative additions of Ca1* revealed that
denervated tissues were 1.5-fold more sensitive to the contractile effect of Ca2’as
compared to control vasa. These authors also observed an increased rate of tension
development to Ca3* in the denervated vas.

Diacvlglvcerol Mass in Rat Vas Deferens

DAG Mass bv Thin Laver Chromatography
Denervated and control vasa treated with NE for up to 10 min showed no
significant change in DAG mass from basal levels as determined by TLC. Using such
a chromatographic method Takuwa et al. (1986) were able to show significant
elevation of DAG mass after stimulating bovine tracheal muscle strips with carbachol.
However, Rembold and Weaver (1990), studying the effect of histamine and
endothelin in swine carotid artery muscle strips, reported no change in DAG mass as
assayed by the DAG kinase method.
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Exposure of both denervated and control vasa to NE appeared to cause a small,
transient decrease in DAG mass but this was not found to be statistically significant.
DAG mass at all time points of NE stimulation were essentially the same in the two
tissue groups.
These results are consistent with those reported by Takenawa et al. (1983) and
Minneman et al. (1988), who observed no significant difference in PIP2 hydrolysis
between denervated and control vas deferens after NE stimulation. However
Takenawa et al. (1983) did report a significant accumulation of phosphatidic acid (PA)
in denervated vasa after NE stimulation for 3 min. Since about a third of cellular
DAG is metabolized to PA by DAG kinase (Majerus et al., 1986), this study was
undertaken to determine if DAG from PIP2 hydrolysis was the source of the elevated
PA levels. The results suggest that the elevation in cellular PA has a source other
than DAG, Membrane-bound phospholipase D has been shown to hydrolyze
phosphatidylcholine to PA (Lassegue et al., 1993) and thus elevated PA levels after
denervation may indicate an enhanced coupling of a-adrenoceptors to
phospholipase D. However the implications for such an alteration in receptor coupling
to contractile function is not clear.

DAG Mass in Control Vas Deferens by HPLC
Using the HPLC technique the mass of DAG in control vas deferens was
determined after stimulation with NE. The mass of monoacylglycerol (MAG) in the
same tissues were simultaneously measured, The basal DAG levels were very similar
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to those obtained by thin layer chromatography. Exposure of the vas deferens to NE
for up to 10 min resulted in no significant accumulation of DAO but rather a small,
transient decrease in mass was observed again. The lack of measurable DAG
accumulation in vasa after NE stimulation as determined by both TLC and HPLC
methods would suggest the observation is not due to limitations in the methods
employed. The initial decrease in DAG mass may be due to increased metabolism or
decreased PIP2 hydrolysis. This initial decrease in DAG mass was accompanied by
similar decreases in MAG; thus, transient loss in DAG is not due to increased
metabolism to MAG. However, after longer periods of NE stimulation (greater than 5
min), MAG began to accumulate rapidly; this is consistent with DAG levels being
held in check by rapid metabolism to MAG (Majerus et al., 1986).

Molecular Species of_DAG in Rat^asJ3eferens
The molecular species of DAG were determined in denervated and control vas
deferens that were at rest or stimulated with NE for 1 or 10 min. The various species
of DAG in denervated and control samples appeared identical by HPLC. Resting
tissues contained DAG lipids with similar retention times as l-stearoyl-2-oleolyl
glycerol, 1 ,2 -dipalmitoyl glycerol, l-palmitoyl-2 -oleoIyI glycerol, 1 ,2 -dioleoyl glycerol
and l-stearoyl-2-arachidonyl glycerol standards. With receptor stimulation the relative
proportion of the 18:0*20:4 DAG (mainly from PIP] hydrolysis) was increased, This
result is consistent with PIP2 hydrolysis after a,-receptor activation in the vas, which
would result in IP, (Minneman et al., 1988) and 18:0-20:4 DAG (Howe and Abdel-
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Latif, 1988) formation. However, this is In apparent contradiction with the earlier data
that showed no change in total DAO mass either by TLC or HPLC methods. This
discrepancy may be due to increased metabolism of total DAQ as well as
accumulation of 18:0-20:4 DAG upon receptor stimulation, the net result being little or
no change in total DAO mass.
This portion of the study was carried out to determine if the source of DAG
production had changed after chronic denervation of the vas deferens. The hypothesis
was that PIP} hydrolysis would remain unchanged but DAG mass would be
significantly increased due to coupling of the receptor to hydrolysis of other membrane
phospholipids (e.g. phosphatidylcholine). Evidence for this type of dual coupling of
the same receptor to different phospholipases has been presented by Plevin et al.
(1991) and Lass£gue et al. (1993). Such an alteration would have resulted in
formation of additional DAG species other than 18:0-20:4, however, the evidence
obtained does not support this hypothesis. The results from the present study, along
with prior data from other labs, would indicate that denervation does not cause an
enhanced coupling of o,-receptors to PIP2 hydrolysis.

PHlPhorbol Dibutvrate Binding Studies

f^HIPDB Binding in Control Vas Deferens
In this study the binding characteristics of membrane-bound PKC were
determined using the specific ligand fH]PDB. Control vasa homogenized in Ca3>-
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containing MOPS buffer produced specific and saturable binding of [3H]PDB. The Kd
values obtained in the present study (3-9 nM) agree well with those obtained for
[JH]PDB binding in mouse brain particulate fraction (7 nM; Dunphy et al., 1980),
mouse brain cytosolic fraction (4 nM; Sharkey et al,, 1984), rat pituitary cells

(8

nM;

Jaken, 1985) and EL4 mouse thymoma cells (11 nM; Sando et al., 1982).
The specific binding of the ligand was also reversible and could be displaced
by increasing concentrations of mezerein, unlabelled PDB and PDA. The non-PKC
activator 4o-phorbol was not able to displace [3H]PDB binding which suggests that
this compound does not bind to PKC. This agrees with the findings of Howe and
Abdel-Latif (1988) who reported no PKC activation by 4cc-phorbol, and Dunphy et al.
(1980) who were unable to displace pH] PDB binding with a 4a-phorbol derivative in
mouse brain. This also explains the lack of contractile response to 4et-phorbol in the
rat vas deferens when compared to PDA and PDB.

j’HlPDB-Binding.in.Deneryated Rat Vas Deferens
There was no significant difference in the specific binding characteristics of
pH]PDB binding between chronically denervated and the paired control vasa. The Kds
obtained from this study were similar to those obtained by other groups. The B ^ for
binding was not altered by denervation either. The similarity between the PKC
binding characteristics of the two samples argues against an increased affinity of PKC
for its endogenous activator (DAO) or elevated resting levels of the enzyme at the
membrane mediating the supersensitive response.
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Protein Kinase C Activity in Rat Vas Deferens

PKC Activity in Control Vas Deferens.and Brain
The PKC assay kit utilized the transfer of J1P, from [3IP]ATP to the substrate
peptide (EGF receptor peptide) by the PKC in the sample. The PKC activity in rat
striatal cytosolic samples was about l.S times greater than in vas deferens, whereas the
activities in the particulate fractions from the two tissues were much the same. The
ratio of cytosolic to particulate activity was almost 3 for brain samples and 2 for vas
deferens. This activity ratio in the vas deferens was much smaller if the tissue was
not homogenized in Ca3f-free conditions, due to a calcium artifact of PKC adhering to
the membrane preparations. Since the reported values of PKC activity vary greatly
due to the assay conditions used by different laboratories, the brain samples were used
as a standard with which to compare the relative amounts of PKC in the vas deferens.
Considering that the brain has the highest reported amounts of PKC (Nishizuka, 1988),
the vas deferens appears to have significant amounts of the enzyme (67% of brain
activity).

Effect of Denervation on NE-induced PKC Activation
The basal activities of PKC in the cytosolic and particulate fractions from
denervated and control vasa were not significantly different. This result is comparable
to that obtained in the binding assays, with about 4 pmol/mg of PKC resulting in
about 4 nmol P( transferred per min per mg protein; an effective PKC activity of about
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1000 molecules of P( transferred per min per mol of enzyme. Vas deferens that were
exposed to NE displayed a time-dependent increase in membrane-associated PKC
activity with accompanying decreases in the cytosolic activity. This result is
consistent with PKC translocating to the membrane from the cytoplasm during
receptor stimulation. Much the same results were obtained by agonist activation of
smooth muscle strips from bovine trachea (Langlands and Diamond, 1992); swine
carotid arteTy (Singer et al., 1992); bovine carotid artery (Haller et al., 1990) and rat
aoria (Bazan et al,, 1992). However, the absolute values reported in these studies vary
widely owing to differing assay conditions and tissues.
In denervated vasa the PKC translocation during receptor stimulation was
maximal within 5 min of NE stimulation and remained elevated for up to 20 min of
stimulation. In contrast, PKC activation in control vas deferens developed more
slowly and reached maximum only after 20 min of NE stimulation. Longer
stimulation times with NE were not carried out in either tissue group. This result is
consistent with an increased rate of PKC activation in the denervated tissues relative to
the control response. Since the amount of DAG is not significantly altered during
receptor activation it would appear that intracellular Ca3\ and not DAG, mediates the
translocation of PKC to the membrane in the vas deferens. A more rapid change in
cytosolic CaJ* would result in faster activation of PKC which could be in place to
augment the receptor-mediated contractile activity.
The PKC activity in the particulate and cytosolic samples assayed in the
absence of Ca3\ PM A and PS were about 10 and 22% of total activity, respectively.
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This small but significant phosphorylation activity in the absence of the cofactors for
PKC would imply the presence of a second protein with similar kinase properties for
the substrate peptide. According to the information in the PKC assay kit protein
kinase A, phosphorylase kinase and the proteolytic fragment of PKC (Ca3\ PMA and
PS independent) are able to generate 8,13 and 38% of the PKC activity, respectively.
Additionally, myosin light chain kinase and hexokinase were not found to have any
activity when assayed with the kit. The Ca3*, PMA and PS-independent activity could
be due to any or a combination of the active proteins that are found in this tissue.
Brain cortex samples assayed with the kit also provided similar amounts of nonspecific
phosphorylating activity.

PKC Activation bv Other Agents
Denervated and control vas deferens exposed to high K*, NKA and PDB also
exhibited significant PKC translocation to the membrane fraction, when compared to
their respective unstimulated tissues. This data is similar to that obtained for K*induced (Ho et al., 1988; Haller et al., 1990) and PDB-induced (Haller et al., 1990;
Singer et al., 1992) PKC translocation in various tissues.
The activation of PKC between denervated and control tissues by these
contractile agents was not significantly different. This is consistent with the lack of
supersensitlve contractile response in denervated vasa after high K*, NKA or phorbol
ester stimulation. Hie ability of K* to produce PKC translocation also suggests a
mechanism by which PKC inhibitors are able to antagonize the contractile response to
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K*-depolarization. It may also indicate that the rise in intracellular Ca3* is the primary
signal for PKC translocation (Ho et al., 1988),
Cytosolic activities of PKC after treatment with these contractile agents were
not significantly different from the respective untreated tissues. The activity of the
enzyme in the denervated sample after PDB, however, was significantly lower than
that in the paired, control sample. The relevance of this result is not readily apparent,
There is considerable evidence that PKC is able to perform multiple functions
in cells, which makes it difficult to correlate its activity with a complex event such as
muscle contraction. Direct biochemical studies have described an inhibitory role for
the enzyme on PIP2 hydrolysis and MLCK-medlated phosphorylation of MLC
(Nishikawa et al., 1984; Itoh et al., 1988; Leeb-Lundberg et al., 1985). Calcium
fluorescence studies have also shown PKC to decrease the amplitude of the
intracellular Ca3* spike after agonist stimulation (Itoh et al., 1988). The enzyme has
been implicated in activating the Ca3*-ATPase pump on the plasma and sarcoplasmic
membrane (Fukuda et al., 1990). Such an action will have the effect of extruding
cytoplasmic CaJ* to the extracellular space as well as increasing its sequestration into
the sarcoplasmic reticulum.
There is also evidence to support a positive role of PKC on smooth muscle
contraction. Itoh et al. (1988) showed that even though the intracellular CaJf spike
after receptor stimulation is depressed by PKC activation, significant attenuation in
contractile activity does not result. The authors ascribe a role for PKC in sensitizing
the contractile elements to Ca3* which leads to equivalent response in the presence of
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lowered Ca1*. This is consistent with the report by Baraban et al. (1985) where PKC
activation (by phorbol esters) augments the receptor-mediated contractile event.
Additionally, Souhrada and Souhrada (1989) and Mironneau et al., (1991) have
presented evidence to support PKC-medlated Ca2* influx into smooth muscle cells.
With PKC playing both inhibitory and stimulatory roles in smooth muscle, it is
conceivable that these processes are chronologically separated. Thus short term PKC
activation could result in positive PKC effects whereas long term activation leads to
negative feedback effects. If such a scenario exists, then a more rapid
translocation/activation of PKC in denervated vas deferens would put the enzyme in a
position to effect positive actions with the normal contractile apparatus.
The existence of PKC isozymes adds further complexity to the role of the
enzyme in situ; particularly with regard to the Ca37phospholipid-independent and
dependent forms. It is possible that the total amount of the enzyme remains
unchanged after denervation of the vas deferens, but the relative amounts of the
various isozymes becomes altered. Singer et al. (1992) and Khalil et al. (1992) have
characterized 5 isozymes of PKC in smooth muscle; three of which are Ca2*-sensitive
(a, p and y) and the rest CaJ*-insensitive (e and ()• Denervation of the vas deferens
may trigger a shift in the PKC population from the Ca2*-sensitive to the insensitive
forms. Thus the PKC-mediated effects may become more apparent at lower cellular
Ca’* concentrations. This would result in PKC-mediated events being less dependent
on Ca1* in the supersensitive vas deferens. The greater than normal response of
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denervated vasa to NE after nifedipine is consistent with such a decrease in the Ca3*
requirement for contractile response.
Ultimately the enhanced contractile response in the denervated rat vas deferens
probably reflects an increased number of actin-myosin crossbridges formed during
receptor stimulation. Such an increase would be mediated by: (i) increased
mobilization of Ca3* by receptor-mediated events; (ii) increased sensitivity of the
contractile proteins to Ca3*; (iii) decreased MLC phosphatase activity which is
responsible for dephosphorylation of MLC and relaxation of muscle; or (iv) some
combination of the three processes working in concert. Of the three major
mechanisms, PKC has been implicated in sensitizing the contractile proteins to Ca3* as
well as decreasing MLC phosphatase activity (Somlyo and Himpens, 1989). The
results obtained herein support a positive role for PKC in the supersensitive response,
but not necessarily as the sole mediator. The net enhanced response of the denervated
vas deferens is most likely a culmination of several cellular processes in adaptation to
the loss in neuronal input. Eventually, elucidation of the mechanism of the
supersensitivity phenomenon will provide information as to how smooth muscle cells
adapt to receptor signalling, as well as provide evidence that neurotransmitters such as
NE are not just contractile agonists but also regulators of primary cellular function
with regard to gene expression, protein synthesis and metabolic activity.
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CHAPTER 5
Summary and Conclusions

1.

The ability of PKC activators, such as PDA and PDB, to elicit contractile

response in the rat vas deferens indicates a role for protein kinase C in the production
as well as the maintenance of muscle contraction in this tissue. The effect of PKC
inhibition leading to depressed receptor and non-receptor-induced contraction would
attest to a fundamental role of PKC in the contractile activity of the normal vas
deferens.

2.

The markedly enhanced response to norepinephrine in the denervated rat vas

deferens is indicative of the development of supersensitivity in this tissue. The
inability of NKA and PDA to elicit an increased response after denervation may point
to a difference in the way these agents produce a contractile response, relative to NE.
The effect of nifedipine antagonizing the NE response in control tissues to a greater
extent than in denervated vasa, is further support for a postjunctional alteration leading
to the supersensitive response. It is also consistent with a change in the source for
Ca3* utilized for muscle contraction after denervation.
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3.

Stimulation of denervated and control vas deferens by NE resulted in no

significant accumulation of the second messenger diacylglycerol. This may be due to
rapid metabolic processes that lead to near constant amounts of tissue DAO. The
molecular species of DAG found in denervated tissues were the same as those in
control vasa and provide support for a lack of change in the coupling of a-receptors to
multiple phospholipases. Rather the receptor appears to be linked to PIP2 hydrolysis
in both denervated and control tissues.

4.

Chronic denervation of the rat vas deferens led to no change in the amount or

binding affinity of membrane-bound PKC. Thus the supersensitive response is not
mediated by an increased basal level of membrane-bound PKC or caused by its
enhanced affinity for activators, phorbol esters or DAO.

5.

NE was able to activate PKC at a faster rate in the denervated vas when

compared to the control response. This alteration may result in PKC being in a
position to more readily augment the Ca3*-mediated contractile function of the tissue.
Neurokinin A, PDB and K*-depolarization produced equivalent PKC translocation in
denervated and control vasa and this is consistent with the similar tissue
responsiveness to these agents after denervation.

6.

The ability of NE to cause PKC translocation in the rat vas deferens without

increasing DAG levels would indicate that DAG is not the primary mediator of this
process. In addition, basal levels of DAG in the tissues were found to be sufficient to
activate at least 50 times the PKC that became associated with the membrane after
receptor stimulation (assuming a mol per mol interaction of DAG and PKC).

7.

The change in the rate of PKC activation and Ca3*-dependence may eventually

point to a changing role of Ca1* in mediating contractile response in the supersensitive
vas deferens, Assuming the tension developed by smooth muscle is proportional to
the number of actin-myosin cross-bridges formed, the supersensitive response would
be indicative of an increase in such an interaction. This increase in actin-myosin
interaction could be mediated by: (i) increased mobilization of Ca1*; (ii) increased
sensitivity of the contractile proteins to Ca3*; (ill) decreased rate of dephosphorylation
of MLC; or (iv) a combination of these three events. Of these possible events this
study provides evidence for increased intracellular Ca1* mobilization and for PKC in
increasing the sensitivity of contractile processes to Ca3*. Thus a direct role for PKC
in mediating the supersensitive response merits further investigation.
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8.

Thus far, the study of denervation supersensitivity has progressed from the

level of the receptor toward the intracellular events mediating contractile function. It
may be more efficient to begin further studies from the more fundamental interactions
of actin and myosin and design the process outward. The increased rate of contractile
force production after denervation warrants the study of MLC phosphorylation
following receptor activation in these (issues. The maximal phasic force produced
should be proportional to the amount of MLC phosphorylated. A significant deviation
from this relationship would point to secondary processes (increased Ca1* sensitivity
or involvement of other cytosolic proteins such as desmin, caldesmon, etc.) playing a
more prominent role in the supersensitive tissue. The altered sensitivity to Ca1*
channel blockers in denervated tissues may reflect a change in the sensitivity of the
contractile apparatus to Ca1*. Contractile studies with the denervated, skinned muscle
preparation could provide evidence for such an alteration. Such a pursuit may
eventually reveal differences in the regulation of smooth muscle after denervation and
provide new insights into cell signal regulation.
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Appendix A
Physiological Salt Solution

Reagents

Stock A (10X concentrate)
Molecular Wt.

Mass (g)

Sodium Chloride

58.44

132.00

Potassium Chloride

74.56

7.08

Calcium Chloride*2HiO

146,99

7.41

Magnesium Sulfate* 7 H2O

246,48

5.88

Dextrose

180.16

20.00

dissolve in distilled water

2000 ml

Stock B (10X concentrate)

Potassium Hyd. phosphate
Sodium bicarbonate

Molecular Wt.

MassJg)

136.09

3.22

84.01

42.00

dissolved in distilled water

2000 ml

Procedure
1.

To make 2 1 of PSS, 200 ml of stock A and B are added in a volummetric
flask and brought up to volume with distilled water.

2.

Addition of distilled water (about 400 ml) between the mixing of stock
solutions prevents precipitation of calcium salts.

Ill
3.

The PSS Is aerated with 5% carbon dioxide in oxygen for about 30 min before
use.
PSS Comuosition

Final Concentration fmM)

NaCl

112.94

KC1

4.75

CaCl2

2.52

MgS04

1.19

Dextrose

5.55

k h 2p o 4

1.18

NaHCOj

25,00

jncentrations
Na*

137.9 mM

Cl*

K*

5.9 mM

PCV* 1.18 mM

Ca1*

2.52 mM

HCOj- 25.0 mM

Mg1* 1.19 mM

122.7 mM
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Appendix B
High K*-containinE PSS

Reagents
Stock A (10X concentrate)
Molecular Wt.

Massis)

NaCl

58.44

7.54

KG

74.56

74.56

GaGx*2HaO

149.99

3.71

MgSoWHjO

246.48

2.94

Dextrose

180.16

10.00

dissolve in distilled water

1000 ml

Stock B (10X concentrate)
Molecular Wt.

Mass fg)

k h 2p o 4

136.09

1.61

NaHCOj

84.01

21.00

dissolve in distilled water

1000 ml

Procedure
1.

To make 100 mM K*-PSS (11) add 100 ml of stock A, dilute with about 200
ml off distilled water and then 100 ml of stock B in 1000 ml volummetric
flask. Bring up to the mark with distilled water.

2.

To make 100 ml of 20 mM K*-PSS, the above solution is diluted with regular
PSS according to the formula:
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[K > 1 0 0 ml - {100 mM K*« X ml) + 5.9 mM (100 - X ml),
which reduces to:
X - {[K*] - 5.9J/0.94,
where [K*] is the desired K* concentration and X is the volume of 100 mM K*
to be diluted.
Thus 15 ml of 100 mM K*-PSS is mixed with 85 ml of regular PSS to obtain 100 ml
of 20 mM K*-PSS.
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Appendix C
Lowry Protein Assay

Reagents
Reagent A:
Sodium carbonate

(2.00%)

lO.OOg

Sodium dodecyl sulfate

(0.50%)

2.50g

Potassium sodium tartrate

(0.02%)

O.lg

Sodium hydroxide

(0.10 N)

2.0g

dissolve in distilled water
Reagent B:

Copper sulfate.5H20

Reagent C:

Mix 50 ml of Reagent A and
1 ml of Reagent B

Reagent D:

Folin and Ciocalteau reagent
diluted with equal volume of distilled water

500 ml

(0,5%, w/v)

Procedure
1.

Sample containing 10-150 pg of protein in 400 pi volumes are used,

2.

Add 2 ml of Reagent C and mix well. Allow the mixture to stand at room
temperature for at least 10 min.

3.

Add 200 pi of Reagent D and vortex immediately. Allow to stand for at least
30 min at room temperature.

4.

Read the absorbance of the mixture in a spectrophotometer at 750 nm, against
appropriate blank mixture.

With each Lowry assay protein standards (bovine serum albumin) are also
assayed. Typically 10-150 pg of BSA are assayed by the same procedure to
produce a standard curve. The curve of Absorbance^ versus protein content
(BSA) is plotted and used to calculate the protein content in the unknown
samples. This is done by the use of GraphPad's linear regression procedure.

Typical standard curve to BSA using the Lowry
protein assay

1,00

I o !°

o

c

0.25
<

0.00

75
100
125
BSA content (ug)

150

175

Figure 23. Data represents the mean (± S.E.M.) of 4 replicates with
linear regression line. The dotted line indicates the 95% confidence
interval.
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Appendix D

Bio-Rad Protein Assay

Reagent
Bio-Rad Protein assay dye reagent concentrate
diluted 1:5 with distilled water.

Procedure
1.

Aliquots of the samples (100 pi) containing 10-150 pg of protein are used.

2.

Add 5 ml of the diluted dye reagent and mix by shaking.

3.

Allow to sit at room temperature for at least 5 min but not longer than 1 hour.

4.

Read the absorbance of the mixture in a spectrophotometer at 595 nm against
appropriate blanks.

5.

Standard protein amounts of bovine-y-globulin (10-200 pg/100 pi) are also
assayed at the same time.

A standard curve for bovine gamma globulin is produced by plotting the
Absorbance^ versus the protein content of the standard. BSA is generally not
used as a standard due to the high amounts of color developed, thus
underestimating the protein in the samples.
This assay was used in the current study to assay for protein in buffers
containing EDTA and EGTA, which give very high blanks when assayed with
the Lowry method.
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Standard curve for bovlne-t-gtobulin using th e
Bio-Rad protein assay reagent

i

s
*

0.8

g 0.6
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0.4

A
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02

0.0

50

100
150
Protein content (ug)

200

Figure 24. Data are represented by the mean (± S.E.M.) of 3 replicates. The
dotted lines are the 95% confidence interval of the regression line.
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